BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306. [PMID: 16420554 DOI: 10.1111/j.1538-7836.2006.01753.x] [Cited by in Crossref: 4110] [Cited by in F6Publishing: 3207] [Article Influence: 256.9] [Reference Citation Analysis]
Number Citing Articles
1 Alessandri C, Conti F, Conigliaro P, Mancini R, Massaro L, Valesini G. Seronegative Autoimmune Diseases. Annals of the New York Academy of Sciences 2009;1173:52-9. [DOI: 10.1111/j.1749-6632.2009.04806.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
2 Schaefer JK, McBane RD, Black DF, Williams LN, Moder KG, Wysokinski WE. Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Thromb Haemost 2014;112:947-50. [PMID: 25118790 DOI: 10.1160/TH14-03-0272] [Cited by in Crossref: 74] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
3 Horimoto AM, Silveira AF, Costa IP. Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis. Rev Bras Reumatol 2016:S0482-5004(15)00164-3. [PMID: 26809482 DOI: 10.1016/j.rbr.2015.09.002] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
4 Martínez-Zamora MÁ, Cervera R, Balasch J. Thromboembolism risk following recurrent miscarriage. Expert Rev Cardiovasc Ther 2013;11:1503-13. [PMID: 24134441 DOI: 10.1586/14779072.2013.839201] [Reference Citation Analysis]
5 Perricone C, Ciccacci C, Ceccarelli F, Di Fusco D, Spinelli FR, Cipriano E, Novelli G, Valesini G, Conti F, Borgiani P. TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development. Immunogenetics 2013;65:703-9. [PMID: 23836313 DOI: 10.1007/s00251-013-0717-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
6 Roggenbuck D, Borghi MO, Somma V, Büttner T, Schierack P, Hanack K, Grossi C, Bodio C, Macor P, von Landenberg P, Boccellato F, Mahler M, Meroni PL. Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers. Arthritis Res Ther 2016;18:111. [PMID: 27209064 DOI: 10.1186/s13075-016-1018-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
7 Riancho-zarrabeitia L, Daroca G, Muñoz P, López-hoyos M, Haya A, Martínez-taboada VM. Serological evolution in women with positive antiphospholipid antibodies. Seminars in Arthritis and Rheumatism 2017;47:397-402. [DOI: 10.1016/j.semarthrit.2017.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
8 Willis R, Gonzalez EB. Pathogenetic mechanisms of antiphospholipid antibody production in antiphospholipid syndrome. World J Rheumatol 2015; 5(2): 59-68 [DOI: 10.5499/wjr.v5.i2.59] [Reference Citation Analysis]
9 Giles I, Yee C, Gordon C. Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nat Rev Rheumatol 2019;15:391-402. [DOI: 10.1038/s41584-019-0240-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
10 Pastori D, Parrotto S, Vicario T, Saliola M, Mezzaroma I, Violi F, Pignatelli P. Antiphospholipid syndrome and anticoagulation quality: a clinical challenge. Atherosclerosis 2016;244:48-50. [PMID: 26584138 DOI: 10.1016/j.atherosclerosis.2015.10.105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
11 Obayashi S, Ozaki Y, Sugi T, Kitaori T, Katano K, Suzuki S, Sugiura-ogasawara M. Antiphosphatidylethanolamine antibodies might not be an independent risk factor for further miscarriage in patients suffering recurrent pregnancy loss. Journal of Reproductive Immunology 2010;85:186-92. [DOI: 10.1016/j.jri.2010.03.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
12 Miesbach W. Malignancies and catastrophic anti-phospholipid syndrome. Clin Rev Allergy Immunol 2009;36:91-7. [PMID: 19048416 DOI: 10.1007/s12016-008-8101-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gérardin M, Giniès JL, Giraut C, Grenet D, Guillot M, Huet F, Le Bourgeois M, Murris-Epin M, Ramel S, Sardet A, Sermet-Gaudelus I, Varaigne F, Wanin S, Weiss L, Hurtaud MF. Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study. J Cyst Fibros 2015;14:97-103. [PMID: 25107684 DOI: 10.1016/j.jcf.2014.05.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
14 Stelzer M, Henes J, Saur S. The Role of Antiphospholipid Antibodies in COVID-19. Curr Rheumatol Rep 2021;23:72. [PMID: 34259944 DOI: 10.1007/s11926-021-01041-7] [Reference Citation Analysis]
15 Aranda F, Udry S, Perés Wingeyer S, Amshoff LC, Bogdanova N, Wieacker P, Latino JO, Markoff A, de Larrañaga G. Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications. J Assist Reprod Genet 2018;35:921-8. [PMID: 29497952 DOI: 10.1007/s10815-018-1142-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
16 Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e152S-e184S. [PMID: 22315259 DOI: 10.1378/chest.11-2295] [Cited by in Crossref: 765] [Cited by in F6Publishing: 612] [Article Influence: 76.5] [Reference Citation Analysis]
17 Žigon P, Ambrožič A, Čučnik S, Kveder T, Rozman B, Božič B. Modified phosphatidylserine-dependent antiprothrombin [corrected] ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies. Clin Chem Lab Med 2011;49:1011-8. [PMID: 21574879 DOI: 10.1515/CCLM.2011.162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
18 Wang M, Zhang P, Yu S, Zhou G, Lv J, Nallapothula D, Guo C, Wang Q, Singh RR. Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss. Clinical Immunology 2019;208:108259. [DOI: 10.1016/j.clim.2019.108259] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
19 Lekovic JP, Friedman CM, Desancho MT. Lingual thrombosis in a woman with antiphospholipid syndrome. Am J Obstet Gynecol 2013;208:e3-4. [PMID: 23313716 DOI: 10.1016/j.ajog.2013.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
20 Udry S, Latino JO, Belizna C, Perés Wingeyer S, Fernández Romero DS, de Larrañaga G. A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome. Immunol Res 2019;67:478-85. [PMID: 31873844 DOI: 10.1007/s12026-019-09110-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Salmon JE, Mineo C, Giles I, Chamley LW, Meroni PL, Abrahams VM. Mechanisms of Antiphospholipid Antibody-Mediated Pregnancy Morbidity. In: Erkan D, Lockshin MD, editors. Antiphospholipid Syndrome. Cham: Springer International Publishing; 2017. pp. 117-43. [DOI: 10.1007/978-3-319-55442-6_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
22 Bu C, Zhang C, Li Z, Gao L, Xie Z, Cai G. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss. Clin Exp Immunol 2007;149:31-9. [PMID: 17425656 DOI: 10.1111/j.1365-2249.2007.03382.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
23 Amigo M. What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)? Lupus 2014;23:1259-61. [DOI: 10.1177/0961203314534307] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
24 Di Rosa R, Ferrero S, Cifani N, Ferri L, Proietta M, Picchianti Diamanti A, Del Porto F. In vitro fertilization and autoimmunity: Evidence from an observational study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019;234:137-42. [DOI: 10.1016/j.ejogrb.2018.12.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Zuily S, Regnault V, Guillemin F, Kaminsky P, Rat A, Lecompte T, Wahl D. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. Thrombosis Research 2013;132:e1-7. [DOI: 10.1016/j.thromres.2013.04.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
26 Sorice M, Buttari B, Capozzi A, Profumo E, Facchiano F, Truglia S, Recalchi S, Alessandri C, Conti F, Misasi R, Valesini G, Riganò R. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome. Clin Exp Immunol 2016;184:174-82. [PMID: 26702877 DOI: 10.1111/cei.12762] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Pliakos C, Alexiadou E, Metallidis S, Papavramidis TS, Kapoulas S, Sapalidis K, Nikolaidis P. Right atrium myxoma coexisting with antiphospholipid syndrome: a case report. Cardiovasc Ultrasound 2009;7:47. [PMID: 19818150 DOI: 10.1186/1476-7120-7-47] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Patel RK, Arya R. Does IgA antibody against β2 glycoprotein I increase cardiovascular risk in hemodialysis patients? Kidney Int 2012;81:1164-6. [PMID: 22648357 DOI: 10.1038/ki.2012.35] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Bertolaccini ML, Sanna G. Recent advances in understanding antiphospholipid syndrome. F1000Res 2016;5:2908. [PMID: 28105326 DOI: 10.12688/f1000research.9717.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
30 Chatterjee S, Pauling JD. Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders. Clin Rheumatol 2021;40:2457-65. [PMID: 32959188 DOI: 10.1007/s10067-020-05399-4] [Reference Citation Analysis]
31 El Hasbani G, Khamashta M, Uthman I. Antiphospholipid syndrome and infertility. Lupus 2020;29:105-17. [DOI: 10.1177/0961203319893763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Meter M, Meter D, Ceprnja T, Perkovic D. Left Atrial Myxoma and Antiphospholipid Syndrome—A Case Report. Int J Angiol. [DOI: 10.1055/s-0041-1740103] [Reference Citation Analysis]
33 Rupa-Matysek J, Gil L, Wojtasińska E, Ciepłuch K, Lewandowska M, Komarnicki M. The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome. Rheumatol Int 2014;34:1599-605. [PMID: 24671503 DOI: 10.1007/s00296-014-2996-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
34 Prouvot J, Aglaé C, Daniel L, Moranne O. A catastrophic antiphospholipid syndrome complicated with heparin-induced thrombocytopaenia, successfully managed with double filtration plasmapheresis, steroids and a direct thrombin inhibitor. BMJ Case Rep 2019;12:e231161. [PMID: 31527216 DOI: 10.1136/bcr-2019-231161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lazzarin N, Exacoustos C, Vaquero E, De Felice G, Manfellotto D, Zupi E. Uterine junctional zone at three-dimensional transvaginal ultrasonography in patients with recurrent miscarriage: a new diagnostic tool? European Journal of Obstetrics & Gynecology and Reproductive Biology 2014;174:128-32. [DOI: 10.1016/j.ejogrb.2013.12.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 Linnemann B, Weingarz L, Schindewolf M, Schwonberg J, Weber A, Herrmann E, Lindhoff-last E. Prevalence of established risk factors for venous thromboembolism according to age. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2014;2:131-9. [DOI: 10.1016/j.jvsv.2013.09.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
37 Musiał J. Antiphospholipid antibodies and thrombosis. Thrombosis Research 2012;129:345-7. [DOI: 10.1016/j.thromres.2011.10.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
38 Latino JO, Udry S, Aranda F, Wingeyer SP, Romero DSF, Belizna C, Larrañaga G. Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine. Lupus 2020;29:1736-42. [PMID: 32838621 DOI: 10.1177/0961203320952850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Reda S, Brügelmann A, Müller J, Oldenburg J, Pötzsch B, Rühl H. Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants. Sci Rep 2020;10:12221. [PMID: 32699227 DOI: 10.1038/s41598-020-69199-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Garrido-gimenez C, Alijotas-reig J. Recurrent miscarriage: causes, evaluation and management. Postgrad Med J 2015;91:151-62. [DOI: 10.1136/postgradmedj-2014-132672] [Cited by in Crossref: 108] [Cited by in F6Publishing: 90] [Article Influence: 15.4] [Reference Citation Analysis]
41 Asherson RA, Cervera R, Klumb E, Stojanovic L, Sarzi-puttini P, Yinh J, Bucciarelli S, Espinosa G, Levy R, Shoenfeld Y. Amputation of Digits or Limbs in Patients with Antiphospholipid Syndrome. Seminars in Arthritis and Rheumatism 2008;38:124-31. [DOI: 10.1016/j.semarthrit.2007.10.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
42 Martínez-Flores JA, Serrano M, Pérez D, Lora D, Paz-Artal E, Morales JM, Serrano A. Detection of circulating immune complexes of human IgA and beta 2 glycoprotein I in patients with antiphospholipid syndrome symptomatology. J Immunol Methods 2015;422:51-8. [PMID: 25865263 DOI: 10.1016/j.jim.2015.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
43 Islam MA, Wong KK, Sasongko TH, Gan SH, Wong JS. Familial primary antiphospholipid syndrome: A report of co-occurrence in three Malaysian family members. Eur J Rheumatol 2016;3:139-41. [PMID: 27733946 DOI: 10.5152/eurjrheum.2015.0068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
44 Godfrey R, O'Hanlon R, Wilson M, Buckley J, Sharma S, Whyte G. Underlying cause discovered for a prior idiopathic AMI. BMJ Case Rep 2011;2011:bcr0220113799. [PMID: 22700481 DOI: 10.1136/bcr.02.2011.3799] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Lally L, Spiera RF. Pulmonary vasculitis. Rheum Dis Clin North Am 2015;41:315-31. [PMID: 25836645 DOI: 10.1016/j.rdc.2015.01.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
46 Ng CJ, McCrae KR, Ashworth K, Sosa LJ, Betapudi V, Manco-Johnson MJ, Liu A, Dong JF, Chung D, White-Adams TC, López JA, Di Paola J. Effects of anti-β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity. Res Pract Thromb Haemost 2018;2:380-9. [PMID: 30046742 DOI: 10.1002/rth2.12090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
47 Bitsadze V, Bouvier S, Khizroeva J, Cochery-Nouvellon É, Mercier É, Perez-Martin A, Makatsariya A, Gris JC. Early ADAMTS13 testing associates with pre-eclampsia occurrence in antiphospholipid syndrome. Thromb Res 2021;203:101-9. [PMID: 33989981 DOI: 10.1016/j.thromres.2021.04.021] [Reference Citation Analysis]
48 Greaves M. Pathogenesis and management of antiphospholipid syndrome. Thrombosis Research 2009;123:S4-9. [DOI: 10.1016/s0049-3848(09)70002-7] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
49 Mineo C. Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep 2013;15:324. [PMID: 23519891 DOI: 10.1007/s11926-013-0324-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
50 Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, Rizzo N, Facchinetti F, Dall'Asta A, Visentin S, Sarno L, Xodo S, Bernabini D, Monari F, Roman A, Eke AC, Hoxha A, Ruffatti A, Schuit E, Martinelli P; PREGNANTS (PREGNancy in women with ANTiphospholipid Syndrome) working group. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol 2017;216:525.e1-525.e12. [PMID: 28153662 DOI: 10.1016/j.ajog.2017.01.026] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 17.4] [Reference Citation Analysis]
51 Margarita A, Batuca J, Scenna G, Alves JD, Lopez L, Iannaccone L, Matsuura E, Ames PR. Subclinical atherosclerosis in primary antiphospholipid syndrome. Ann N Y Acad Sci 2007;1108:475-80. [PMID: 17894012 DOI: 10.1196/annals.1422.050] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
52 Pericleous C, Ferreira I, Borghi O, Pregnolato F, McDonnell T, Garza-Garcia A, Driscoll P, Pierangeli S, Isenberg D, Ioannou Y, Giles I, Meroni PL, Rahman A. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. PLoS One 2016;11:e0156407. [PMID: 27253369 DOI: 10.1371/journal.pone.0156407] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 7.8] [Reference Citation Analysis]
53 Raschi E, Privitera D, Bodio C, Lonati PA, Borghi MO, Ingegnoli F, Meroni PL, Chighizola CB. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis. Arthritis Res Ther 2020;22:265. [PMID: 33168071 DOI: 10.1186/s13075-020-02360-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
54 Meroni PL, Chighizola CB, Rovelli F, Gerosa M. Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther 2014;16:209. [PMID: 25166960 DOI: 10.1186/ar4549] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 10.4] [Reference Citation Analysis]
55 Sciascia S, Branch DW, Levy RA, Middeldorp S, Pavord S, Roccatello D, Ruiz-Irastorza G, Tincani A, Khamashta M, Schreiber K, Hunt BJ. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. Thromb Haemost 2016;115:285-90. [PMID: 26421409 DOI: 10.1160/TH15-06-0491] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
56 Oliveira DC, Correia A, Oliveira C. The Issue of the Antiphospholipid Antibody Syndrome. J Clin Med Res 2020;12:286-92. [PMID: 32489503 DOI: 10.14740/jocmr4154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Schellong SM. [Importance of thrombophilia screening]. Internist (Berl) 2014;55:529-30, 532-4, 536. [PMID: 24733637 DOI: 10.1007/s00108-013-3423-4] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
58 Pullmann R, Bonilla E, Phillips PE, Middleton FA, Perl A. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis Rheum 2008;58:532-40. [DOI: 10.1002/art.23161] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
59 FialovÁ L, KuchaŘ O, PetrÁČkovÁ M, Malbohan I, Zima T. Avidity of anti-phospholipid antibodies in relation to their levels. Cent Eur J Immunol 2020;45:136-43. [PMID: 33456323 DOI: 10.5114/ceji.2020.97901] [Reference Citation Analysis]
60 Swadzba J, Musial J. More on: the debate on antiphospholipid syndrome classification criteria. Journal of Thrombosis and Haemostasis 2009;7:501-2. [DOI: 10.1111/j.1538-7836.2009.03274.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
61 Yang W, Kang MK, Ha SY, Kang DW, Bae J, Lee EJ, Jeong HY, Kim JM, Jung KH, Lee SH. Current status and role of antiphospholipid antibody testing in cryptogenic stroke. Eur J Neurol 2021. [PMID: 34800314 DOI: 10.1111/ene.15191] [Reference Citation Analysis]
62 Giacomelli R, Afeltra A, Alunno A, Bartoloni-bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D’angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG. Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. Autoimmunity Reviews 2019;18:93-106. [DOI: 10.1016/j.autrev.2018.08.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 15.3] [Reference Citation Analysis]
63 Manukyan G, Martirosyan A, Slavik L, Margaryan S, Ulehlova J, Mikulkova Z, Hlusi A, Papajik T, Kriegova E. Anti-domain 1 β2 glycoprotein antibodies increase expression of tissue factor on monocytes and activate NK Cells and CD8+ cells in vitro. Auto Immun Highlights 2020;11:5. [PMID: 32127041 DOI: 10.1186/s13317-020-00128-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
64 Baptista FS, Bortolotto MRDFL, Bianchini FRM, Krebs VLJ, Zugaib M, Francisco RPV. Can thrombophilia worsen maternal and perinatal outcomes in cases of severe preeclampsia? Pregnancy Hypertension 2018;11:81-6. [DOI: 10.1016/j.preghy.2017.12.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
65 Middeldorp S. Low-molecular-weight heparins have no place in recurrent miscarriage: Debate – For the motion. Thrombosis Research 2011;127:S105-9. [DOI: 10.1016/s0049-3848(11)70028-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
66 Keeling D, Mackie I, Moore GW, Greer IA, Greaves M; British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157:47-58. [PMID: 22313321 DOI: 10.1111/j.1365-2141.2012.09037.x] [Cited by in Crossref: 279] [Cited by in F6Publishing: 219] [Article Influence: 27.9] [Reference Citation Analysis]
67 Hoxha A, Calligaro A, Bortolati M, Tonello M, Guariso G, Ruffatti A. The antiphospholipid syndrome and infections in a child with trisomy 21. Autoimmun Rev 2008;8:121-3. [PMID: 18573354 DOI: 10.1016/j.autrev.2008.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
68 Bazzan M, Vaccarino A. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients. Intern Emerg Med 2009;4:61-2. [PMID: 19082904 DOI: 10.1007/s11739-008-0209-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Tsonis O, Balogun S, Adjei JO, Mogekwu O, Iliodromiti S. Management of recurrent miscarriages: an overview of current evidence. Curr Opin Obstet Gynecol 2021;33:370-7. [PMID: 34419993 DOI: 10.1097/GCO.0000000000000735] [Reference Citation Analysis]
70 Mekinian A, Costedoat-Chalumeau N, Masseau A, Tincani A, De Caroli S, Alijotas-Reig J, Ruffatti A, Ambrozic A, Botta A, Le Guern V, Fritsch-Stork R, Nicaise-Roland P, Carbonne B, Carbillon L, Fain O. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Autoimmun Rev 2015;14:23-9. [PMID: 25179813 DOI: 10.1016/j.autrev.2014.08.040] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
71 Frauenknecht K, Bargiotas P, Bauer H, von Landenberg P, Schwaninger M, Sommer C. Neuroprotective effect of Fn14 deficiency is associated with induction of the granulocyte-colony stimulating factor (G-CSF) pathway in experimental stroke and enhanced by a pathogenic human antiphospholipid antibody. J Neuroimmunol. 2010;227:1-9. [PMID: 20557950 DOI: 10.1016/j.jneuroim.2010.05.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
72 Li CZ, Li CC, Hsieh CC, Lin MC, Hueng DY, Liu FC, Chen YH. Fatal antiphospholipid syndrome following endoscopic transnasal-transsphenoidal surgery for a pituitary tumor: A case report. Medicine (Baltimore) 2017;96:e5774. [PMID: 28072724 DOI: 10.1097/MD.0000000000005774] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Inês L, Rodrigues M, Jesus D, Fonseca FP, Silva JAP. Risk of damage and mortality in SLE patients fulfilling the ACR or only the SLICC classification criteria. A 10-year, inception cohort study. Lupus 2018;27:556-63. [DOI: 10.1177/0961203317731534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
74 Bor MV, Jacobsen IS, Gram JB, Sidelmann JJ. Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-β2-glycoprotein I antibodies: a systematic evaluation according to the guidelines. Lupus 2018;27:1446-54. [PMID: 29848159 DOI: 10.1177/0961203318776105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
75 Wiest NE, Johns GS, Edwards E. A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization. Vaccines (Basel) 2021;9:903. [PMID: 34452028 DOI: 10.3390/vaccines9080903] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Tolbert J, Carpenter SL. Common acquired causes of thrombosis in children. Curr Probl Pediatr Adolesc Health Care 2013;43:169-77. [PMID: 23890024 DOI: 10.1016/j.cppeds.2013.05.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
77 Vargas-Hitos JA, Sabio JM, Navarrete-Navarrete N, Zamora-Pasadas M, Jiménez-Alonso J. Severe digital necrosis as the clinical onset of antiphospholipid syndrome. Intern Emerg Med 2016;11:761-2. [PMID: 26494470 DOI: 10.1007/s11739-015-1335-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
78 Zhou Z, Teng J, Sun Y, Liu H, Cheng X, Su Y, Yang C, Ye J. Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China. Clin Rheumatol 2019;38:3161-8. [PMID: 31290022 DOI: 10.1007/s10067-019-04670-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 Gupta A, Shah U, Khine H, Vandergriff T, Froehlich T. Antiphospholipid syndrome associated with combined immune checkpoint inhibitor therapy. Melanoma Research 2017;27:171-3. [DOI: 10.1097/cmr.0000000000000335] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
80 Chemello D, Rosa L, de Araujo AF, de Araujo PC, Pereira LCC, Hillesheim SF, Saffi MAL. Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review. J Vasc Bras 2021;20:e20200036. [PMID: 34093674 DOI: 10.1590/1677-5449.200036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Dufendach KA, Seese L, Stearns B, Hickey G, Mathier M, Keebler M, Chen S, Sciortino CM, Thoma FW, Kilic A. Outcomes of left ventricular assist device implantation in hypercoagulable patients. J Card Surg 2020;35:2201-7. [PMID: 32720362 DOI: 10.1111/jocs.14710] [Reference Citation Analysis]
82 Battinelli EM, Marshall A, Connors JM. The role of thrombophilia in pregnancy. Thrombosis. 2013;2013:516420. [PMID: 24455235 DOI: 10.1155/2013/516420] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
83 Di Simone N, D'ippolito S, Marana R, Di Nicuolo F, Castellani R, Pierangeli SS, Chen P, Tersigni C, Scambia G, Meroni PL. Antiphospholipid Antibodies Affect Human Endometrial Angiogenesis: Protective Effect of a Synthetic Peptide (TIFI) Mimicking the Phospholipid Binding Site of β 2 glycoprotein I. Am J Reprod Immunol 2013;70:299-308. [DOI: 10.1111/aji.12130] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
84 Liu H, Li P, Li K, Zhou Z, Zhou Y, Leng X, Zhao L, Zhang X. Monoclonal gammopathy in autoimmune diseases: Analysis and follow-up of 160 cases in a tertiary center in China. Clin Immunol 2021;234:108909. [PMID: 34915197 DOI: 10.1016/j.clim.2021.108909] [Reference Citation Analysis]
85 Lin WS, Chen PC, Yang CD, Cho E, Hahn BH, Grossman J, Hwang KK, Chen PP. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum 2007;56:1638-47. [PMID: 17469158 DOI: 10.1002/art.22522] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
86 Nakashima MO, Rogers HJ. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res 2014;49:85-94. [PMID: 25025009 DOI: 10.5045/br.2014.49.2.85] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
87 Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Kalman B, Minagar A, Munschauer FE, Galey TM, Hussein S, Bakshi R, Zivadinov R. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis. J Neurol 2010;257:63-71. [PMID: 19633967 DOI: 10.1007/s00415-009-5264-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
88 Gustafsson JT, Svenungsson E. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Autoimmunity 2014;47:67-76. [PMID: 24228980 DOI: 10.3109/08916934.2013.856005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
89 Meroni P, Raschi E, Grossi C, Pregnolato F, Trespidi L, Acaia B, Borghi M. Obstetric and vascular APS: Same autoantibodies but different diseases? Lupus 2012;21:708-10. [DOI: 10.1177/0961203312438116] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
90 Cerdà P, Becattini C, Iriarte A, Hernández JC, Corbella X, Riera-Mestre A. Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis. Eur J Intern Med 2020;79:43-50. [PMID: 32482595 DOI: 10.1016/j.ejim.2020.05.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
91 Racine A, Nahon S, Jouannaud V, Caugant H, Lesgourgues B. Portal vein thrombosis in a patient with quiescent Crohn's disease associated with hyperhomocysteinemia and antiphospholipid antibody syndrome 1-yr after an ileocecal resection. Am J Gastroenterol 2008;103:499-501. [PMID: 18289225 DOI: 10.1111/j.1572-0241.2007.01646_18.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
92 Dieudonné Y, Guffroy A, Poindron V, Sprauel PS, Martin T, Korganow AS, Gies V. B cells in primary antiphospholipid syndrome: Review and remaining challenges. Autoimmun Rev 2021;20:102798. [PMID: 33722752 DOI: 10.1016/j.autrev.2021.102798] [Reference Citation Analysis]
93 Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, Salmon JE, Shoenfeld Y, Shovman O, Hunt BJ. Antiphospholipid syndrome. Nat Rev Dis Primers 2018;4:17103. [PMID: 29321641 DOI: 10.1038/nrdp.2017.103] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 21.5] [Reference Citation Analysis]
94 Kenar G, Atay K, Yüksek GE, Öz B, Koca SS. Gastrointestinal vasculitis due to systemic lupus erythematosus treated with rituximab: a case report. Lupus 2020;29:640-3. [PMID: 32188302 DOI: 10.1177/0961203320910803] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Choi MY, Barber MR, Barber CE, Clarke AE, Fritzler MJ. Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care. Lupus 2016;25:838-49. [PMID: 27252260 DOI: 10.1177/0961203316640367] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
96 Edwards CJ, Hughes GRV. Hughes syndrome (the antiphospholipid syndrome): 25 years old. Modern Rheumatology 2014;18:119-24. [DOI: 10.3109/s10165-008-0042-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
97 Bucci T, Ames PRJ, Triggiani M, Parente R, Ciampa A, Pignatelli P, Pastori D; Multicenter ATHERO-APS Study group. Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study. Thromb Res 2022;209:69-74. [PMID: 34891057 DOI: 10.1016/j.thromres.2021.12.001] [Reference Citation Analysis]
98 Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken) 2020;72:461-88. [PMID: 32090466 DOI: 10.1002/acr.24130] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 18.5] [Reference Citation Analysis]
99 Mariotti C, Giovannini A, Reibaldi M, Saitta A, Viti F, Nicolai M. Atypical presentation of antiphospholipid syndrome: a case report. Case Rep Ophthalmol 2014;5:400-4. [PMID: 25566061 DOI: 10.1159/000368889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
100 Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020;370:m2177. [PMID: 32759284 DOI: 10.1136/bmj.m2177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
101 Liu T, Gu J, Wan L, Hu Q, Teng J, Liu H, Cheng X, Ye J, Su Y, Sun Y, Chi H, Zhou Z, Jia J, Wang Z, Zhou J, Norman GL, Wang X, Yang C, Shi H. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome. Thromb Res 2020;185:142-9. [PMID: 31816554 DOI: 10.1016/j.thromres.2019.11.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
102 Tian Y, Xu J, Chen D, Yang C, Peng B. The additional use of hydroxychloroquine can improve the live birth rate in pregnant women with persistent positive antiphospholipid antibodies: A systematic review and meta-analysis. J Gynecol Obstet Hum Reprod 2021;50:102121. [PMID: 33746078 DOI: 10.1016/j.jogoh.2021.102121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Garcia D, Akl EA, Carr R, Kearon C. Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood 2013;122:817-24. [DOI: 10.1182/blood-2013-04-496257] [Cited by in Crossref: 76] [Cited by in F6Publishing: 58] [Article Influence: 8.4] [Reference Citation Analysis]
104 Stradner MH, Dejaco C, Zwerina J, Fritsch-Stork RD. Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic. Front Med (Lausanne) 2020;7:562142. [PMID: 33154972 DOI: 10.3389/fmed.2020.562142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
105 Nielly H, Mathian A, Cazenave M, Izzedine H, Haroche J, Cohen-Aubart F, Hie M, Miyara M, Pineton de Chambrun M, Benameur N, Hausfater P, Pha M, Boutin-Lê Thi Huong D, Rouvier P, Brocheriou I, Cluzel P, Amoura Z. Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics. Nephrol Dial Transplant 2020;35:1721-9. [PMID: 31157889 DOI: 10.1093/ndt/gfz085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
106 Meroni PL, Borghi MO. Diagnostic laboratory tests for systemic autoimmune rheumatic diseases: unmet needs towards harmonization. Clin Chem Lab Med 2018;56:1743-8. [PMID: 29708880 DOI: 10.1515/cclm-2018-0066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
107 Spinillo A, Beneventi F, Epis OM, Montanari L, Mammoliti D, Ramoni V, Di Silverio E, Alpini C, Caporali R, Montecucco C. The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome. Am J Obstet Gynecol 2008;199:632.e1-6. [PMID: 18667193 DOI: 10.1016/j.ajog.2008.05.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
108 Abouda A, Hajjej Z, Mansart A, Kaabechi W, Mahmoud DE, Lamine O, Ghazouani E, Ferjani M, Labbene I, Jiao P. Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients. Journal of Immunology Research 2022;2022:1-8. [DOI: 10.1155/2022/9775111] [Reference Citation Analysis]
109 Shaban A, Leira EC. Neurological Complications in Patients with Systemic Lupus Erythematosus. Curr Neurol Neurosci Rep 2019;19:97. [PMID: 31773306 DOI: 10.1007/s11910-019-1012-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
110 Martinez-zamora MA, Tassies D, Carmona F, Espinosa G, Cervera R, Reverter JC, Balasch J. ORIGINAL ARTICLE: Thrombin Activatable Fibrinolysis Inhibitor and Clot Lysis Time in Pregnant Patients with Antiphospholipid Syndrome: Relationship with Pregnancy Outcome and Thrombosis: TAFI AND CLT AS MARKERS OF OUTCOME IN APS PREGNANCIES. American Journal of Reproductive Immunology 2009;62:381-9. [DOI: 10.1111/j.1600-0897.2009.00751.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
111 Hadaya K, Ferrari-lacraz S, Fumeaux D, Boehlen F, Toso C, Moll S, Martin P, Villard J. Eculizumab in Acute Recurrence of Thrombotic Microangiopathy After Renal Transplantation: Eculizumab, TMA and Kidney Transplantation. American Journal of Transplantation 2011;11:2523-7. [DOI: 10.1111/j.1600-6143.2011.03696.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 6.8] [Reference Citation Analysis]
112 Islabão AG, Trindade VC, da Mota LMH, Andrade DCO, Silva CA. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects. Paediatr Drugs 2021. [PMID: 34904182 DOI: 10.1007/s40272-021-00484-w] [Reference Citation Analysis]
113 Dal Ben ER, do Prado CH, Baptista TS, Bauer ME, Staub HL. Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome. J Clin Immunol. 2013;33:876-879. [PMID: 23354908 DOI: 10.1007/s10875-012-9857-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
114 Usuku H, Yamamoto E, Noguchi M, Komorita T, Takae M, Oike F, Yamanaga K, Ito M, Fujisue K, Sueta D, Kanazawa H, Araki S, Arima Y, Takashio S, Nakamura T, Suzuki S, Kawano H, Soejima H, Kaikita K, Matsushita K, Fukui T, Matsui H, Tsujita K. Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease. Int J Cardiol 2021;328:152-7. [PMID: 33359278 DOI: 10.1016/j.ijcard.2020.12.053] [Reference Citation Analysis]
115 Otaduy C, Gobbi CA, Álvarez A, Albiero EH, Yorio MA, Alba Moreyra P. Is lupus nephritis a prognosis factor for pregnancy? Maternal and foetal outcomes. Reumatol Clin (Engl Ed) 2021:S2173-5743(21)00165-9. [PMID: 34538769 DOI: 10.1016/j.reumae.2021.02.008] [Reference Citation Analysis]
116 Kee TP, Venkatanarasimha N, Mohideen SMH, Chan LL, Gogna A, Schaefer PW, Chia GS, Choi YS, Chen RC. A Tale of Two Organ Systems: Imaging review of diseases affecting the thoracic and neurological systems. Part 1. Curr Probl Diagn Radiol 2021:S0363-0188(21)00107-9. [PMID: 34304949 DOI: 10.1067/j.cpradiol.2021.06.008] [Reference Citation Analysis]
117 Barcellona D, Fenu L, Vannini ML, Piras M, Marongiu F. Antiphospholipid syndrome patients: The performance of Coagucheck XS in the monitoring of Vitamin K-Antagonists. Thrombosis Research 2012;129:e168-70. [DOI: 10.1016/j.thromres.2012.01.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
118 Farooqui S, Thong B, Teoh S. Neuroretinitis as an initial presentation of lupus-like illness with antiphospholipid syndrome. Lupus 2010;19:1662-4. [DOI: 10.1177/0961203310377220] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
119 Cohen D, Buurma A, Goemaere NN, Girardi G, le Cessie S, Scherjon S, Bloemenkamp KW, de Heer E, Bruijn JA, Bajema IM. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. J Pathol 2011;225:502-11. [PMID: 21688269 DOI: 10.1002/path.2893] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]
120 Kolyada A, Ke Q, Karageorgos I, Mahlawat P, Barrios DA, Kang PM, Beglova N. Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome. J Thromb Haemost 2016;14:1298-307. [PMID: 26990752 DOI: 10.1111/jth.13314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
121 Belhocine M, Coutte L, Martin Silva N, Morel N, Guettrot-Imbert G, Paule R, Le Jeunne C, Fredi M, Dreyfus M, Piette JC, Souchaud-Debouverie O, Deneux-Tharaux C, Tsatsaris V, Pannier E, Le Guern V, Costedoat-Chalumeau N. Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women. Arthritis Res Ther 2018;20:249. [PMID: 30400982 DOI: 10.1186/s13075-018-1745-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Medina G, Cimé Aké EA, Vera-Lastra O, Saavedra MÁ, Cruz-Domínguez MDP, Amigo MC, Jara LJ. Damage index for antiphospholipid syndrome during long term follow-up: Correlation between organ damage accrual and quality of life. Lupus 2021;30:96-102. [PMID: 33176566 DOI: 10.1177/0961203320970651] [Reference Citation Analysis]
123 Fujieda Y, Amengual O. New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndrome. Eur J Rheumatol 2020. [PMID: 33226327 DOI: 10.5152/eurjrheum.2020.20058] [Reference Citation Analysis]
124 Cueva S, Burks C, McQueen D, Barkoff MS, Stephenson MD. Maternal antithyroid antibodies and euploid miscarriage in women with recurrent early pregnancy loss. Fertil Steril 2018;110:452-8. [PMID: 30098697 DOI: 10.1016/j.fertnstert.2018.04.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
125 Orquevaux P, Masseau A, Le Guern V, Gayet V, Vauthier D, Guettrot-Imbert G, Huong DLT, Wechsler B, Morel N, Cacoub P, Pennaforte JL, Piette JC, Costedoat-Chalumeau N. In Vitro Fertilization in 37 Women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome: A Series of 97 Procedures. J Rheumatol 2017;44:613-8. [PMID: 28089975 DOI: 10.3899/jrheum.160462] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
126 Garcia C, Perandini L, Seguro L, Gualano B, Roschel H, Bonfa E, Borba E, Sá-pinto A. Impaired aerobic exercise capacity and cardiac autonomic control in primary antiphospholipid syndrome. Lupus 2013;22:928-31. [DOI: 10.1177/0961203313497415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
127 Pourrat O, Pierre F. [Medical assessment after a pre-eclampsia: why? for whom? when? how? for what purpose?]. Rev Med Interne 2010;31:766-71. [PMID: 20801558 DOI: 10.1016/j.revmed.2010.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
128 Yelnik CM, Dubucquoi S, Houfflin-debarge V, Lambert M. Anticorps antiphosphatidyléthanolamine, un marqueur du syndrome des antiphospholipides ? La Presse Médicale 2015;44:284-91. [DOI: 10.1016/j.lpm.2014.06.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
129 Simmons DP, Herskovits AZ, Battinelli EM, Schur PH, Lemire SJ, Dorfman DM. Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity. Clinical Chemistry and Laboratory Medicine (CCLM) 2018;56:1289-96. [DOI: 10.1515/cclm-2015-0790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Camous J, Decrombecque T, Louvain-quintard V, Doubine S, Dartevelle P, Stéphan F. Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy. European Journal of Cardio-Thoracic Surgery 2014;46:116-20. [DOI: 10.1093/ejcts/ezt572] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
131 Forastiero R. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation. Lupus 2014;23:1252-4. [DOI: 10.1177/0961203314531635] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
132 Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, Hernández-Ramírez D, Bockenstedt PL, Liaw PC, Cabral AR, Knight JS. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol 2015;67:2990-3003. [PMID: 26097119 DOI: 10.1002/art.39247] [Cited by in Crossref: 157] [Cited by in F6Publishing: 143] [Article Influence: 26.2] [Reference Citation Analysis]
133 Tebo AE. Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation. Lupus 2014;23:1313-6. [PMID: 25228736 DOI: 10.1177/0961203314544534] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
134 Hoang TT, Ichinose K, Morimoto S, Furukawa K, Le LH, Kawakami A. Measurement of anti-suprabasin antibodies, multiple cytokines and chemokines as potential predictive biomarkers for neuropsychiatric systemic lupus erythematosus. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108980] [Reference Citation Analysis]
135 Syuto T, Shimizu A, Takeuchi Y, Tanaka S, Hasegawa M, Nagai Y, Tamura A, Ishikawa O. Association of antiphosphatidylserine/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus. Clin Rheumatol 2009;28:841-5. [DOI: 10.1007/s10067-009-1123-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
136 Chighizola CB, Pregnolato F, Andreoli L, Bodio C, Cesana L, Comerio C, Gerosa M, Grossi C, Kumar R, Lazzaroni MG, Mahler M, Mattia E, Nalli C, Norman GL, Raimondo MG, Ruffatti A, Tonello M, Trespidi L, Tincani A, Borghi MO, Meroni PL. Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome. J Autoimmun 2018;90:76-83. [PMID: 29454510 DOI: 10.1016/j.jaut.2018.02.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
137 Francès C, Barete S, Soria A. Manifestations dermatologiques du syndrome des antiphospholipides. La Revue de Médecine Interne 2012;33:200-5. [DOI: 10.1016/j.revmed.2011.10.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
138 Chen D, Tzang B, Chen Y, Lan J, Tsai C, Hsu T. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome. Clinica Chimica Acta 2010;411:1084-9. [DOI: 10.1016/j.cca.2010.04.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
139 Selmi C, De Santis M, Battezzati PM, Generali E, Lari SA, Ceribelli A, Isailovic N, Zermiani P, Neidhöfer S, Matthias T, Scirè CA, Baldassarre D, Zuin M. Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population. Int J Cardiol 2020;300:209-13. [PMID: 31757648 DOI: 10.1016/j.ijcard.2019.10.042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
140 Favaloro EJ, Henry BM, Lippi G. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? Semin Thromb Hemost 2021. [PMID: 34130340 DOI: 10.1055/s-0041-1728832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Ibrahim AA, El-Lebedy D, Ashmawy I, Hady MA. Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt. Clin Rheumatol 2017;36:1305-10. [PMID: 28185016 DOI: 10.1007/s10067-017-3567-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
142 Ağar Ç, van Os GMA, Mörgelin M, Sprenger RR, Marquart JA, Urbanus RT, Derksen RHWM, Meijers JCM, de Groot PG. β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood 2010;116:1336-43. [DOI: 10.1182/blood-2009-12-260976] [Cited by in Crossref: 178] [Cited by in F6Publishing: 158] [Article Influence: 14.8] [Reference Citation Analysis]
143 Frostegård AG, Su J, von Landenberg P, Frostegård J. Effects of anti-cardiolipin antibodies and IVIg on annexin A5 binding to endothelial cells: implications for cardiovascular disease. Scand J Rheumatol 2010;39:77-83. [PMID: 20132075 DOI: 10.3109/03009740903124432] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
144 Cheemalavagu S, McCoy SS, Knight JS. Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome. BMJ Case Rep 2020;13:e232907. [PMID: 32041760 DOI: 10.1136/bcr-2019-232907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
145 Abu-Zeinah G, Oromendia C, DeSancho MT. Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience. J Thromb Thrombolysis 2019;48:233-9. [PMID: 30835035 DOI: 10.1007/s11239-019-01836-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Rand JH. The antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2007;:136-42. [PMID: 18024621 DOI: 10.1182/asheducation-2007.1.136] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
147 Favaloro EJ. The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA). Am J Hematol 2019;94:1290-6. [PMID: 31379004 DOI: 10.1002/ajh.25606] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
148 Stricker RB, Johnson L. Antiphospholipid antibodies in patients with persistent Lyme disease symptoms. Lupus 2012;21:346-7. [PMID: 22040690 DOI: 10.1177/0961203311425531] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
149 Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG; AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository. Arthritis Care Res (Hoboken) 2019;71:134-41. [PMID: 29669399 DOI: 10.1002/acr.23584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
150 Erkan D. Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome. Arthritis Rheumatol 2021. [PMID: 34114366 DOI: 10.1002/art.41891] [Reference Citation Analysis]
151 Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, Ageno W. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thrombosis Research 2009;124:256-8. [DOI: 10.1016/j.thromres.2009.01.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 83] [Article Influence: 8.4] [Reference Citation Analysis]
152 Korkmaz C. Is food anaphylaxis a cause of antiphospholipid syndrome and thrombosis or a coincidence? Allergol Immunopathol (Madr) 2011;39:313-4. [PMID: 21676526 DOI: 10.1016/j.aller.2011.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Rodríguez García JL, Khamashta MA. Clinical advances of interest in the diagnosis and treatment of patients with antiphospholipid syndrome. Rev Clin Esp (Barc) 2013;213:108-13. [PMID: 22673391 DOI: 10.1016/j.rce.2012.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
154 Ali O, Slagle WS, Hamp AM. Case report: Branch retinal vein occlusion and primary antiphospholipid syndrome. Optometry - Journal of the American Optometric Association 2011;82:428-33. [DOI: 10.1016/j.optm.2010.07.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
155 Ghillani P, Dufat L, Himeur S, Miyara M, Amoura Z, Musset L. Routine use of Zenit RA, a novel chemiluminescent immunoanalyzer in autoimmune disease diagnosis. Auto Immun Highlights 2012;3:27-31. [PMID: 26000125 DOI: 10.1007/s13317-012-0032-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
156 Bernard TJ, Manco-Johnson MJ, Goldenberg NA. The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke. Thromb Res 2011;127:6-12. [PMID: 20947137 DOI: 10.1016/j.thromres.2010.09.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
157 Chighizola CB, de Jesus GR, Branch DW. The hidden world of anti-phospholipid antibodies and female infertility: A literature appraisal. Autoimmun Rev 2016;15:493-500. [PMID: 26827907 DOI: 10.1016/j.autrev.2016.01.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
158 Lopera-vallejo AF, Alijotas-reig J. Anticuerpos antifosfolipídicos y fracaso implantatorio recurrente en fertilización in vitro. El debate continúa. Medicina Clínica 2011;137:697-701. [DOI: 10.1016/j.medcli.2010.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
159 Di Simone N, Di Nicuolo F, D'ippolito S, Castellani R, Tersigni C, Caruso A, Meroni P, Marana R. Antiphospholipid Antibodies Affect Human Endometrial Angiogenesis1. Biology of Reproduction 2010;83:212-9. [DOI: 10.1095/biolreprod.110.083410] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
160 Cacciapaglia F, Vadacca M, Coppolino G, Buzzulini F, Rigon A, Zennaro D, Zardi E, Afeltra A. Spontaneous splenorenal shunt in a patient with antiphospholipid syndrome: the first case reported. Lupus. 2007;16:56-58. [PMID: 17283587 DOI: 10.1177/0961203306072390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
161 Yelnik CM, Nguyen Y, Le Guern V, Hachulla E, Lambert M. Thrombocytopenia in primary antiphospholipid syndrome, a marker of high-risk patients? European Journal of Internal Medicine 2020;74:106-7. [DOI: 10.1016/j.ejim.2020.01.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
162 Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, Cervera R, Crowther M, Dentali F, Erkan D, Espinosa G, Khamashta M, Meerpohl JJ, Moffat K, O'brien S, Pengo V, Rand JH, Rodriguez Pinto I, Thom L, Iorio A. McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome. J Thromb Haemost 2018;16:1656-64. [DOI: 10.1111/jth.14192] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
163 Ulrich V, Konaniah ES, Lee WR, Khadka S, Shen YM, Herz J, Salmon JE, Hui DY, Shaul PW, Mineo C. Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice. J Am Heart Assoc 2014;3:e001369. [PMID: 25315347 DOI: 10.1161/JAHA.114.001369] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
164 Chighizola CB, Meroni PL. Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment. Curr Rheumatol Rep 2018;20:44. [PMID: 29850957 DOI: 10.1007/s11926-018-0741-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
165 Caprio F, Bernstein RA. Duration of anticoagulation after cerebral venous sinus thrombosis. Neurocrit Care 2012;16:335-42. [PMID: 22189571 DOI: 10.1007/s12028-011-9661-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
166 Li XY, Duan HJ, Liu XY, Deng XL. Change of serum B-cell activating factor level in patients with positive antiphospholipid antibodies and previous adverse pregnancy outcomes and its significance. Chin Med J (Engl) 2020;133:2287-94. [PMID: 32842014 DOI: 10.1097/CM9.0000000000000948] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
167 Kampylafka EI, Alexopoulos H, Kosmidis ML, Panagiotakos DB, Vlachoyiannopoulos PG, Dalakas MC, Moutsopoulos HM, Tzioufas AG. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One 2013;8:e55843. [PMID: 23424638 DOI: 10.1371/journal.pone.0055843] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 6.2] [Reference Citation Analysis]
168 Ortel TL. Antiphospholipid syndrome: laboratory testing and diagnostic strategies. Am J Hematol 2012;87 Suppl 1:S75-81. [PMID: 22473619 DOI: 10.1002/ajh.23196] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
169 B Rathna R, Dhali A, Varghese AK, H Balakrishnan C. Rare association of haemophagocytic lymphohistiocytosis (HLH) and antiphospholipid syndrome (APS) in postpartum period: a considerable overlap? BMJ Case Rep 2022;15:e247376. [PMID: 35110287 DOI: 10.1136/bcr-2021-247376] [Reference Citation Analysis]
170 Xiao M, Zhang Y, Zhang S, Qin X, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C, Zhao J, Sun X, Tian R, Wu W, Wu D, Ma J, Chen Y, Zhang D, Xie J, Yan X, Zhou X, Liu Z, Wang J, Du B, Qin Y, Gao P, Lu M, Hou X, Wu X, Zhu H, Xu Y, Zhang W, Li T, Zhang F, Zhao Y, Li Y, Zhang S. Antiphospholipid Antibodies in Critically Ill Patients With COVID-19. Arthritis Rheumatol 2020;72:1998-2004. [PMID: 32602200 DOI: 10.1002/art.41425] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 23.5] [Reference Citation Analysis]
171 Sciascia S, Breen K, Hunt BJ. Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism. Blood Coagul Fibrinolysis 2015;26:476-7. [PMID: 25923780 DOI: 10.1097/MBC.0000000000000247] [Cited by in Crossref: 40] [Cited by in F6Publishing: 10] [Article Influence: 6.7] [Reference Citation Analysis]
172 Wigren M, Svenungsson E, Mattisson IY, Gustafsson JT, Gunnarsson I, Zickert A, Elvin K, Jensen-urstad K, Bengtsson A, Gullstrand B, Fredrikson GN, Nilsson J. Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis. Atherosclerosis 2018;270:1-7. [DOI: 10.1016/j.atherosclerosis.2018.01.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
173 Ames PR, Merashli M, Chis Ster I, D'Andrea G, Iannaccone L, Marottoli V, Margaglione M, Brancaccio V. Survival in primary antiphospholipid syndrome. A single-centre cohort study. Thromb Haemost 2016;115:1200-8. [PMID: 26864875 DOI: 10.1160/TH15-10-0839] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
174 Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Okazaki T, Yamada H, Ozaki S, Kawahata K. Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome. PLoS One 2018;13:e0196172. [PMID: 29723256 DOI: 10.1371/journal.pone.0196172] [Reference Citation Analysis]
175 Alessandri C, Conti F, Pendolino M, Mancini R, Valesini G. New autoantigens in the antiphospholipid syndrome. Autoimmunity Reviews 2011;10:609-16. [DOI: 10.1016/j.autrev.2011.04.011] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
176 George D, Erkan D. Antiphospholipid syndrome. Prog Cardiovasc Dis 2009;52:115-25. [PMID: 19732604 DOI: 10.1016/j.pcad.2009.06.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
177 Clark CA, Davidovits J, Spitzer KA, Laskin CA. The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic. Blood 2013;122:341-7. [DOI: 10.1182/blood-2013-02-485839] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
178 Sibilia J. Comment définir et classer les maladies inflammatoires? Revue du Rhumatisme 2007;74:714-25. [DOI: 10.1016/j.rhum.2007.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
179 Phatak S, Redkar N, Patil MA, Karnik ND. Antiphospholipid syndrome presenting as pulmonary thrombosis and pancreatitis in a young man. BMJ Case Rep 2012;2012:bcr2012006348. [PMID: 23235100 DOI: 10.1136/bcr-2012-006348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Pengo V. Additional laboratory tests to improve on the diagnosis of antiphospholipid syndrome. J Thromb Haemost 2020;18:1846-8. [PMID: 32428999 DOI: 10.1111/jth.14896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
181 Ciccacci C, Perricone C, Politi C, Rufini S, Ceccarelli F, Cipriano E, Alessandri C, Latini A, Valesini G, Novelli G, Conti F, Borgiani P. A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication. Lupus 2017;26:841-8. [DOI: 10.1177/0961203316679528] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
182 Gladd DA, Olech E. Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes. Curr Rheumatol Rep 2009;11:43-51. [PMID: 19171111 DOI: 10.1007/s11926-009-0007-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
183 Pierangeli SS. Novel therapies for the antiphospholipid syndrome. Expert Rev Clin Immunol 2008;4:193-203. [PMID: 20477050 DOI: 10.1586/1744666X.4.2.193] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Joseph FG, Habboush HW. The antiphospholipid syndrome and its 'non-criteria' manifestations. Pract Neurol 2018;18:82-3. [PMID: 29449418 DOI: 10.1136/practneurol-2017-001846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Flessa C, Vlachiotis S, Nezos A, Andreakos E, Mavragani CP, Tektonidou MG. Independent association of low IFNλ1 gene expression and type I IFN score/IFNλ1 ratio with obstetric manifestations and triple antiphospholipid antibody positivity in primary antiphospholipid syndrome. Clinical Immunology 2019;209:108265. [DOI: 10.1016/j.clim.2019.108265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
186 Serrano M, Espinosa G, Lalueza A, Bravo-Gallego LY, Diaz-Simón R, Garcinuño S, Gil-Etayo J, Moises J, Naranjo L, Prieto-González S, Ruiz-Ortiz E, Sánchez B, Moreno-Castaño AB, Díaz-Pedroche C, Viñas-Gomis O, Cervera R, Serrano A; APS-COVID 19 Study Group/European Forum on Antiphospholipid Antibodies. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019. ACR Open Rheumatol 2021;3:267-76. [PMID: 33738987 DOI: 10.1002/acr2.11245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
187 Yee DZY, Teng GG, Lim AYN, Low AF, Vasoo S. The autoimmunity conundrum: clotting or inflammation: Autoimmunity conundrum: clotting or inflammation. International Journal of Rheumatic Diseases 2010;13:e62-6. [DOI: 10.1111/j.1756-185x.2010.01534.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
188 Shimamura Y, Maeda T, Abe K, Ogawa Y, Takizawa H. Selective immunoglobulin M deficiency complicated by systemic lupus erythematosus and antiphospholipid syndrome: a case report and review of literature. CEN Case Rep 2021;10:435-41. [PMID: 33616883 DOI: 10.1007/s13730-021-00583-0] [Reference Citation Analysis]
189 Pasquali J, Poindron V, Korganow A, Martin T. The antiphospholipid syndrome. Best Practice & Research Clinical Rheumatology 2008;22:831-45. [DOI: 10.1016/j.berh.2008.08.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
190 Lippi G, Favaloro EJ, Franchini M. Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT. J Thromb Thrombolysis 2012;34:360-6. [DOI: 10.1007/s11239-012-0753-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
191 Spielmann L, Nespola B, Séverac F, Andres E, Kessler R, Guffroy A, Poindron V, Martin T, Geny B, Sibilia J, Meyer A. Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes. Ann Rheum Dis 2019;78:1101-6. [PMID: 31126956 DOI: 10.1136/annrheumdis-2018-214439] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
192 Carbone J, Gallego A, Lanio N, Navarro J, Orera M, Aguaron A, Fernandez-Cruz E, Sarmiento E. Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome. J Rheumatol 2009;36:1217-25. [PMID: 19332638 DOI: 10.3899/jrheum.081079] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
193 de Larrañaga G, Bottaro E, Martinuzzo M, Figueroa R, Iglesias Varela ML, Perés Wingeyer S, Forastiero R, Adamczuk Y, Corti M, Puga L, Benetucci J. Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? The first case-control study. Clin Appl Thromb Hemost 2009;15:340-7. [PMID: 18160564 DOI: 10.1177/1076029607310217] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
194 Murphy CH, Jin J, Zehnder JL. Antiphospholipid Antibodies in Patients With Lupus Anticoagulant Prozone Effect. Am J Clin Pathol 2020;153:229-34. [PMID: 31598704 DOI: 10.1093/ajcp/aqz151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Petri M. Pregnancy and Systemic Lupus Erythematosus. Best Pract Res Clin Obstet Gynaecol 2020;64:24-30. [PMID: 31677989 DOI: 10.1016/j.bpobgyn.2019.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
196 Loustau V, Debouverie O, Canoui-Poitrine F, Baili L, Khellaf M, Touboul C, Languille L, Loustau M, Bierling P, Haddad B, Godeau B, Pourrat O, Michel M. Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol 2014;166:929-35. [PMID: 24957165 DOI: 10.1111/bjh.12976] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
197 Gadó K, Domján G. [Antiphospholipid syndrome and pregnancy]. Orv Hetil 2012;153:1207-18. [PMID: 22846489 DOI: 10.1556/OH.2012.29425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
198 Linge P, Arve S, Olsson LM, Leonard D, Sjöwall C, Frodlund M, Gunnarsson I, Svenungsson E, Tydén H, Jönsen A, Kahn R, Johansson Å, Rönnblom L, Holmdahl R, Bengtsson A. NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus. Ann Rheum Dis 2020;79:254-61. [PMID: 31704719 DOI: 10.1136/annrheumdis-2019-215820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
199 Panopoulos S, Thomas K, Georgiopoulos G, Boumpas D, Katsiari C, Bertsias G, Drosos AA, Boki K, Dimitroulas T, Garyfallos A, Papagoras C, Katsimbri P, Tziortziotis A, Adamichou C, Kaltsonoudis E, Argyriou E, Vosvotekas G, Sfikakis PP, Vassilopoulos D, Tektonidou MG. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study. Rheumatology (Oxford) 2021;60:170-8. [PMID: 32596727 DOI: 10.1093/rheumatology/keaa321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Salle V, Mazière JC, Brulé A, Schmidt J, Smail A, Duhaut P, Mazière C, Makdassi R, Choukroun G, Betsou F, Ducroix JP. Antibodies against the N-terminal domain of annexin A2 in antiphospholipid syndrome. Eur J Intern Med 2012;23:665-8. [PMID: 22939813 DOI: 10.1016/j.ejim.2012.04.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
201 Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, Berghella V, Nazareth A, Tahlak M, McIntyre HD, Da Silva Costa F, Kihara AB, Hadar E, McAuliffe F, Hanson M, Ma RC, Gooden R, Sheiner E, Kapur A, Divakar H, Ayres-de-Campos D, Hiersch L, Poon LC, Kingdom J, Romero R, Hod M. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet 2021;152 Suppl 1:3-57. [PMID: 33740264 DOI: 10.1002/ijgo.13522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
202 Marziale A, Bettacchioli E, Picart G, Nafai S, Galinat H, Meroni PL, Frostegard J, Alarcon-Riquelme ME, Renaudineau Y; PRECISESADS Clinical Consortium. Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases. J Autoimmun 2020;115:102524. [PMID: 32693965 DOI: 10.1016/j.jaut.2020.102524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Ahn SS, Jung SM, Yoo J, Lee SW, Song JJ, Park YB. Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening. Rheumatol Int 2019;39:1859-66. [PMID: 31468123 DOI: 10.1007/s00296-019-04435-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
204 Alvarez AM, Neubeck S, Parra S, Markert UR, Cadavid AP. Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome. J Hum Reprod Sci 2017;10:10-7. [PMID: 28479750 DOI: 10.4103/0974-1208.204018] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
205 Lavoipierre V, Talbot M, Soubrier C, De Sainte Marie B, Seux V, Solas C, Morange P, Bernit E, Ebbo M, Faucher B, Harlé JR, Schleinitz N. [Bilateral adrenal hemorrhage under apixaban in primary antiphospholipid syndrome]. Rev Med Interne 2020;41:489-92. [PMID: 31672255 DOI: 10.1016/j.revmed.2019.09.003] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
206 Costedoat-chalumeau N, Saadoun D, Piette J. Le syndrome des antiphospholipides en 2012 : son hétérogénéité impose une prise en charge personnalisée. La Revue de Médecine Interne 2012;33:173-5. [DOI: 10.1016/j.revmed.2012.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
207 Yang Z, Shen X, Zhou C, Wang M, Liu Y, Zhou L. Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis. Lupus 2021;30:70-9. [PMID: 33081590 DOI: 10.1177/0961203320967097] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Khizroeva J, Nalli C, Bitsadze V, Lojacono A, Zatti S, Andreoli L, Tincani A, Shoenfeld Y, Makatsariya A. Infertility in women with systemic autoimmune diseases. Best Practice & Research Clinical Endocrinology & Metabolism 2019;33:101369. [DOI: 10.1016/j.beem.2019.101369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
209 Mora-Ramirez M, Gonzalez-Pacheco H, Amezcua-Guerra LM. The Impact of Primary Antiphospholipid Syndrome on Long-term Cardiovascular Outcomes After Percutaneous Coronary Intervention and Stenting in Patients With Myocardial Infarction. J Clin Rheumatol 2018;24:169-73. [PMID: 29239935 DOI: 10.1097/RHU.0000000000000651] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
210 Tincani A, Taraborelli M, Cattaneo R. Antiphospholipid antibodies and malignancies. Autoimmunity Reviews 2010;9:200-2. [DOI: 10.1016/j.autrev.2009.04.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
211 Gibbins KJ, Ware Branch D. Pre-eclampsia as a manifestation of antiphospholipid syndrome: assessing the current status. Lupus 2014;23:1229-31. [PMID: 25228712 DOI: 10.1177/0961203314531347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
212 Muñoz SA, Aranda F, Allievi A, Orden AO, Perés Wingeyer S, Trobo R, Alvarez A, Eimon A, Barreira JC, Schneeberger E, Dal Pra F, Sarano J, Hofman J, Chamorro J, de Larrañaga G. 4G/5G plasminogen activator inhibitor-1 and −308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis. Clin Exp Med 2014;14:83-9. [DOI: 10.1007/s10238-012-0221-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
213 Hong JY, Lai CC, Chang YS, Hsiao KH, Chou CT, Chen WS. Intestinal vasculitis and renal infarction in a lupus patient with antiphospholipid syndrome. J Clin Rheumatol 2012;18:383. [PMID: 22832302 DOI: 10.1097/RHU.0b013e318264236b] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
214 Gavriilaki E, Brodsky RA. Complementopathies and precision medicine. J Clin Invest 2020;130:2152-63. [PMID: 32310222 DOI: 10.1172/JCI136094] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 36.0] [Reference Citation Analysis]
215 Beneventi F, Locatelli E, Alpini C, Lovati E, Ramoni V, Simonetta M, Cavagnoli C, Spinillo A. Association between previously unknown connective tissue disease and subclinical hypothyroidism diagnosed during first trimester of pregnancy. Fertility and Sterility 2015;104:1195-201. [DOI: 10.1016/j.fertnstert.2015.07.1158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
216 Yi HJ, Kim JH, Koo HS, Bae JY, Cha SW, Yang KM. Elevated natural killer cell levels and autoimmunity synergistically decrease uterine blood flow during early pregnancy. Obstet Gynecol Sci 2014;57:208-15. [PMID: 24883292 DOI: 10.5468/ogs.2014.57.3.208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
217 Sobhani NC, Shulman R, Tran EE, Gonzalez JM. Early Onset Severe Hypertensive Disease in Pregnancy and Screening for Antiphospholipid Syndrome. AJP Rep 2020;10:e32-6. [PMID: 32140289 DOI: 10.1055/s-0040-1702926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Gordon O, Almagor Y, Fridler D, Mandel A, Qutteineh H, Yanir A, Reif S, Revel Vilk S. De novo neonatal antiphospholipid syndrome: A case report and review of the literature. Seminars in Arthritis and Rheumatism 2014;44:241-5. [DOI: 10.1016/j.semarthrit.2014.04.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
219 Angelillo-Scherrer A, Mansouri Taleghani B, Förger F, Baerlocher GM, Pabst T, Pöllinger A, Banz Y, Geiser T, Kremer Hovinga JA, Rovó A. Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome. Blood Adv 2019;3:2664-7. [PMID: 31506284 DOI: 10.1182/bloodadvances.2019000465] [Reference Citation Analysis]
220 Chighizola C, Moia M, Meroni P. New oral anticoagulants in thrombotic antiphospholipid syndrome. Lupus 2014;23:1279-82. [DOI: 10.1177/0961203314540968] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
221 Rodrigues CEM, Bonfá E, Caleiro MTC, Vendramini MB, Bueno C, Lopes JB, de Carvalho JF. Association of arterial events with the coexistence of metabolic syndrome and primary antiphospholipid syndrome. Arthritis Care Res 2012;64:1576-83. [DOI: 10.1002/acr.21701] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
222 Bazzan M, Montaruli B, Vaccarino A, Fornari G, Saitta M, Prandoni P. Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study. Intern Emerg Med 2009;4:491-5. [PMID: 19784751 DOI: 10.1007/s11739-009-0316-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
223 Meroni PL, Macor P, Durigutto P, De Maso L, Gerosa M, Ferraresso M, Borghi MO, Mollnes TE, Tedesco F. Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery. Blood 2016;127:365-7. [DOI: 10.1182/blood-2015-09-672139] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
224 Damoiseaux J, Andrade LE, Fritzler MJ, Shoenfeld Y. Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention. Autoimmun Rev 2015;14:555-63. [PMID: 25661979 DOI: 10.1016/j.autrev.2015.01.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 7.6] [Reference Citation Analysis]
225 Oliver-Miñarro D, Sanchez-Ramón S, Rodriguez-Mahou M, Alvarez S, Fernández-Cruz E. Isolated type 5 antimitochondrial autoantibodies are associated with a history of thrombocytopenia and fetal loss. Fertil Steril 2007;87:976.e17-8. [PMID: 17222839 DOI: 10.1016/j.fertnstert.2006.07.1535] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
226 Meroni PL, Shoenfeld Y. Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies. Autoimmun Rev 2008;7:585-7. [PMID: 18706525 DOI: 10.1016/j.autrev.2008.08.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
227 Lazzaroni MG, Dall’ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. Journal of Autoimmunity 2016;74:106-17. [DOI: 10.1016/j.jaut.2016.06.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 7.7] [Reference Citation Analysis]
228 Ramirez GA, Efthymiou M, Isenberg DA, Cohen H. Under crossfire: thromboembolic risk in systemic lupus erythematosus. Rheumatology 2019;58:940-52. [DOI: 10.1093/rheumatology/key307] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
229 Tan Y, Bian Y, Song Y, Zhang Q, Wan X. Exosome-Contained APOH Associated With Antiphospholipid Syndrome. Front Immunol 2021;12:604222. [PMID: 34040601 DOI: 10.3389/fimmu.2021.604222] [Reference Citation Analysis]
230 DeSpenza RA, Jones DM, Chamley LW, Abrahams VM. Antiphospholipid antibody-induced trophoblast responses are differentially modulated by viral dsRNA and viral ssRNA. Am J Reprod Immunol 2021;:e13516. [PMID: 34904767 DOI: 10.1111/aji.13516] [Reference Citation Analysis]
231 El Hadidi KT, Medhat BM, Abdel Baki NM, Abdel Kafy H, Abdelrahaman W, Yousri AY, Attia DH, Eissa M, El Dessouki D, Elgazzar I, Elgengehy FT, El Ghobashy N, El Hadary H, El Mardenly G, El Naggar H, El Nahas AM, El Refai RM, El Rwiny HA, Elsman RM, Galal M, Ghoniem S, Maged LA, Sally SM, Naji H, Saad S, Shaaban M, Sharaf M, Sobhy N, Soliman RM, El Hadidi TS. Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center. Lupus 2018;27:1030-8. [DOI: 10.1177/0961203317751856] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
232 Chen RX, Zhou YZ, Li PC, Yang HX, Fei YY, Hu XM, Wu W, Zhao LD, Chen H, Zhang X. The efficacy and safety of antithrombotic therapy in patients with positive antiphospholipid antibodies receiving invasive procedures: experience from a single tertiary center. Clin Rheumatol 2019;38:1897-904. [PMID: 30847686 DOI: 10.1007/s10067-019-04483-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
233 Kirkegaard K, Heegaard S, Hvas AM. No evidence for thrombophilia in patients with retinal venous occlusion: a systematic GRADE-based review. Acta Ophthalmol 2017;95:12-9. [PMID: 27573507 DOI: 10.1111/aos.13214] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
234 Viall CA, Chen Q, Stone PR, Chamley LW. Human extravillous trophoblasts bind but do not internalize antiphospholipid antibodies. Placenta 2016;42:9-16. [PMID: 27238708 DOI: 10.1016/j.placenta.2016.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
235 Kumar A. How to investigate new-onset polyarthritis. Best Practice & Research Clinical Rheumatology 2014;28:844-59. [DOI: 10.1016/j.berh.2015.04.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
236 Ricci G, Simeone R. Thrombophilic screening in clinical practice should be evidence-based. Human Reproduction 2008;23:2609-2609. [DOI: 10.1093/humrep/den311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
237 Baqai T, Ioannou Y. Comparison of juvenile and adult onset systemic lupus erythematosus. British Journal of Hospital Medicine 2012;73:558-63. [DOI: 10.12968/hmed.2012.73.10.558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
238 Kim H, Kim J, Hwang SM, Lee HR, Han K, Kim HK. Synergistic Thrombotic Risk of Antibodies Against Phosphatidylserine and Prothrombin and β-2-Glycoprotein I. Clin Appl Thromb Hemost 2014;20:442-7. [DOI: 10.1177/1076029613497424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
239 Wirestam L, Arve S, Linge P, Bengtsson AA. Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Front Immunol 2019;10:2734. [PMID: 31824510 DOI: 10.3389/fimmu.2019.02734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
240 Bećarević M, Mirković D, Ignjatović S. Double positivity of the IgG isotype of both anticardiolipin and anti-β2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary data. Clin Rheumatol 2016;35:2947-54. [PMID: 27743141 DOI: 10.1007/s10067-016-3438-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
241 Devreese KM. Antiphospholipid antibody testing and standardization. Int J Lab Hematol 2014;36:352-63. [PMID: 24750682 DOI: 10.1111/ijlh.12234] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
242 Gao N, Wang ZL, Li MT, Han SM, Dang YQ, Zhang FC, Shi TY, Zhang LN, Zeng XF. Clinical characteristics and risk factors of intracranial hemorrhage in systemic lupus erythematosus. Lupus 2013;22:453-60. [PMID: 23554034 DOI: 10.1177/0961203313477226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
243 Viner M, Murakhovskaya I. A rare combination of thrombotic thrombocytopenic purpura and antiphospholipid syndrome. Blood Coagul Fibrinolysis 2017;28:411-5. [PMID: 27898514 DOI: 10.1097/MBC.0000000000000608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
244 Yang YW, Chen YH, Xirasagar S, Lin HC. Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 2011;42:319-23. [PMID: 21164122 DOI: 10.1161/STROKEAHA.110.596361] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
245 Idborg H, Zandian A, Sandberg AS, Nilsson B, Elvin K, Truedsson L, Sohrabian A, Rönnelid J, Mo J, Grosso G, Kvarnström M, Gunnarsson I, Lehtiö J, Nilsson P, Svenungsson E, Jakobsson PJ. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives. Arthritis Res Ther 2019;21:62. [PMID: 30777133 DOI: 10.1186/s13075-019-1836-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
246 Faliti CE, Gualtierotti R, Rottoli E, Gerosa M, Perruzza L, Romagnani A, Pellegrini G, De Ponte Conti B, Rossi RL, Idzko M, Mazza EMC, Bicciato S, Traggiai E, Meroni PL, Grassi F. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J Exp Med 2019;216:317-36. [PMID: 30655308 DOI: 10.1084/jem.20171976] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
247 Grika EP, Ziakas PD, Zintzaras E, Moutsopoulos HM, Vlachoyiannopoulos PG. Morbidity, Mortality, and Organ Damage in Patients with Antiphospholipid Syndrome. J Rheumatol 2012;39:516-23. [DOI: 10.3899/jrheum.110800] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
248 Pengo V, Banzato A, Bison E, Zoppellaro G, Padayattil Jose S, Denas G. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial. Lupus 2016;25:301-6. [DOI: 10.1177/0961203315611495] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
249 Funke A, Staub HL, Monticielo OA, Balbi GGM, Danowski A, Santiago MB, Andrade DCOD, Rêgo J. Non-criteria Antiphospholipid Antibodies: a narrative review. Rev Assoc Med Bras 2020;66:1595-601. [DOI: 10.1590/1806-9282.66.11.1595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Mahler M, Norman GL, Meroni PL, Khamashta M. Autoantibodies to domain 1 of beta 2 glycoprotein 1: A promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmunity Reviews 2012;12:313-7. [DOI: 10.1016/j.autrev.2012.05.006] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 7.4] [Reference Citation Analysis]
251 Skeith L. Anticoagulating patients with high-risk acquired thrombophilias. Blood 2018;132:2219-29. [DOI: 10.1182/blood-2018-05-848697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
252 Parajuli S, Lockridge JB, Langewisch ED, Norman DJ, Kujovich JL. Hypercoagulability in Kidney Transplant Recipients. Transplantation. 2016;100:719-726. [PMID: 26413991 DOI: 10.1097/tp.0000000000000887] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
253 Kutteh WH. Antiphospholipid antibody syndrome and reproduction. Current Opinion in Obstetrics & Gynecology 2014;26:260-5. [DOI: 10.1097/gco.0000000000000086] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
254 Castro Ferreira CD, da Mota LMH, Vanderley Oliveira AC, de Carvalho JF, Corrêa Lima RA, Simaan CK, Sousa Rabelo FD, Sarmento JA, de Oliveira RB, Santos Neto LLD. Frequency of sexual dysfunction in women with rheumatic diseases. Revista Brasileira de Reumatologia (English Edition) 2013;53:35-46. [DOI: 10.1016/s2255-5021(13)70004-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
255 Castro-Marrero J, Balada E, Vilardell-Tarrés M, Ordi-Ros J. The PTPN22*R620W polymorphism does not confer genetic susceptibility to antiphospholipid syndrome in the Spanish population. Int J Immunogenet 2011;38:529-31. [PMID: 21923648 DOI: 10.1111/j.1744-313X.2011.01038.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
256 Nelson SM, Greer IA. The potential role of heparin in assisted conception. Human Reproduction Update 2008;14:623-45. [DOI: 10.1093/humupd/dmn031] [Cited by in Crossref: 92] [Cited by in F6Publishing: 72] [Article Influence: 6.6] [Reference Citation Analysis]
257 Giannakopoulos B, Gao L, Qi M, Wong JW, Yu DM, Vlachoyiannopoulos PG, Moutsopoulos HM, Atsumi T, Koike T, Hogg P, Qi JC, Krilis SA. Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis. J Autoimmun 2012;39:121-9. [PMID: 22704541 DOI: 10.1016/j.jaut.2012.05.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
258 Deák M, Bocskai M, Burcsár S, Dányi O, Fekete Z, Kovács L. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome. Lupus 2014;23:913-8. [DOI: 10.1177/0961203314531839] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
259 Woller SC, Stevens SM, Kaplan DA, Branch DW, Aston VT, Wilson EL, Gallo HM, Johnson EG, Rondina MT, Lloyd JF, Evans RS, Elliott CG. Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS). Clin Appl Thromb Hemost 2016;22:239-47. [DOI: 10.1177/1076029615615960] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
260 Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers 2020;6:7. [PMID: 31974366 DOI: 10.1038/s41572-019-0141-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 28.5] [Reference Citation Analysis]
261 Clark KE, Giles I. Antiphospholipid syndrome. Medicine 2018;46:118-25. [DOI: 10.1016/j.mpmed.2017.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
262 Hoppe B, Burmester G, Dörner T. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Current Opinion in Rheumatology 2011;23:299-304. [DOI: 10.1097/bor.0b013e328344c3f7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
263 Pradella P, Azzarini G, Santarossa L, Caberlotto L, Bardin C, Poz A, D'Aurizio F, Giacomello R. Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays. Clin Chem Lab Med 2013;51:379-85. [PMID: 23001319 DOI: 10.1515/cclm-2012-0382] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
264 El Amraoui M, Bounnyit H, Zemmez Y, Bouhamidi A, Hassam B, Senouci K. [Multiple and extensive skin necrosis revealing anti phospholipid antibody syndrome]. Pan Afr Med J 2016;25:56. [PMID: 28250880 DOI: 10.11604/pamj.2016.25.56.10572] [Reference Citation Analysis]
265 Bouvier S, Cochery-nouvellon É, Lavigne-lissalde G, Mercier É, Marchetti T, Balducchi J, Marès P, Gris J. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 2014;123:404-13. [DOI: 10.1182/blood-2013-08-522623] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 11.4] [Reference Citation Analysis]
266 Hisada R, Kato M, Sugawara E, Fujieda Y, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study. J Thromb Haemost 2017;15:1782-7. [DOI: 10.1111/jth.13763] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
267 Ames PR. Antiphospholipid antibodies in systemic sclerosis: a double oxidative hit? Clin Rheumatol 2009;28:881-2. [PMID: 19513779 DOI: 10.1007/s10067-009-1210-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
268 Silver RM. Catastrophic antiphospholipid syndrome and pregnancy. Semin Perinatol 2018;42:26-32. [PMID: 29179957 DOI: 10.1053/j.semperi.2017.11.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
269 Benkirane A, Devalet B, Montigny P, London F. Late-onset of primary antiphospholipid syndrome: a case report. Acta Neurol Belg 2021;121:1375-6. [PMID: 33242192 DOI: 10.1007/s13760-020-01555-4] [Reference Citation Analysis]
270 Lerang K, Gilboe I, Gran JT. Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus. Rheumatology 2012;51:663-9. [DOI: 10.1093/rheumatology/ker318] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
271 Shirai T, Fujii H, Ono M, Nakamura K, Watanabe R, Tajima Y, Takasawa N, Ishii T, Harigae H. A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus. Arthritis Res Ther 2012;14:R157. [PMID: 22747982 DOI: 10.1186/ar3897] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
272 Cervera R, Conti F, Doria A, Iaccarino L, Valesini G. Does seronegative antiphospholipid syndrome really exist? Autoimmun Rev 2012;11:581-4. [PMID: 22036830 DOI: 10.1016/j.autrev.2011.10.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
273 Linnemann B, Schmidt H, Schindewolf M, Erbe M, Zgouras D, Grossmann R, Schambeck C, Lindhoff-Last E. Etiology and VTE risk factor distribution in patients with inferior vena cava thrombosis. Thromb Res. 2008;123:72-78. [PMID: 18295303 DOI: 10.1016/j.thromres.2008.01.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
274 Lefèvre G, Zéphir H, Warembourg F, Michelin E, Pruvo JP, Hachulla E, Semah F, Dubucquoi S, Lenfant P, Vermersch P, Hatron PY, Prin L, Launay D. [Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus]. Rev Med Interne 2012;33:491-502. [PMID: 22579860 DOI: 10.1016/j.revmed.2012.03.356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
275 Lu C, Liu Y, Jiang H. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. The Journal of Maternal-Fetal & Neonatal Medicine 2019;32:1299-311. [DOI: 10.1080/14767058.2017.1404979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
276 Madazli R, Yuksel MA, Oncul M, Imamoglu M, Yilmaz H. Obstetric outcomes and prognostic factors of lupus pregnancies. Arch Gynecol Obstet 2014;289:49-53. [PMID: 23807699 DOI: 10.1007/s00404-013-2935-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
277 Luo L, Wu Y, Niu T, Han Y, Feng Y, Ding Q, Huang R, Zhang X, Feng J, Hou M, Peng J, Li Y, Zhou Y, Su L, Yang L, Zhou Z, Xue F, Gu J, Zhu T, Wang X, Deng J, Mei H, Hu Y. A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation. Thromb Res 2019;173:131-40. [PMID: 30529391 DOI: 10.1016/j.thromres.2018.11.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
278 Larcher R, Pineton de Chambrun M, Garnier F, Rubenstein E, Carr J, Charbit J, Chalard K, Mourad M, Amalric M, Platon L, Brunot V, Amoura Z, Jaber S, Jung B, Luyt CE, Klouche K. One-Year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Cohort Study. Chest 2020;158:1017-26. [PMID: 32289313 DOI: 10.1016/j.chest.2020.03.050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
279 Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Coloma-Bazan E, de Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A, Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K, Llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina I; (EUROAPS Study Group Collaborators). The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. Autoimmun Rev 2015;14:387-95. [PMID: 25555817 DOI: 10.1016/j.autrev.2014.12.010] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 10.5] [Reference Citation Analysis]
280 Andrade D, Bortolotto L, Bonfá E, Borba E. Primary antiphospholipid syndrome: absence of premature atherosclerosis in patients without traditional coronary artery disease risk factors. Lupus 2016;25:472-8. [PMID: 26585072 DOI: 10.1177/0961203315617841] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
281 Sugiura-Ogasawara M, Nozawa K, Nakanishi T, Hattori Y, Ozaki Y. Complement as a predictor of further miscarriage in couples with recurrent miscarriages. Hum Reprod 2006;21:2711-4. [PMID: 16790609 DOI: 10.1093/humrep/del229] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
282 Crespillo-Andújar C, Calbacho Robles M, Norman FF, Pérez-Molina JA. Severe immune thrombocytopaenia in a patient taking benznidazole for chronic Chagas disease. BMJ Case Rep 2018;2018:bcr-2017-223788. [PMID: 29588298 DOI: 10.1136/bcr-2017-223788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
283 Sciascia S, Radin M, Cecchi I, Fenoglio R, De Marchi A, Besso L, Baldovino S, Rossi D, Miraglia P, Rubini E, Roccatello D. Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. J Nephrol 2020;33:757-62. [PMID: 31974856 DOI: 10.1007/s40620-019-00698-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
284 You Y, Shi C, Zhou Z, Wang F, Sun Y, Teng J, Liu H, Cheng X, Su Y, Shi H, Yang C, Ye J. Rituximab in thrombotic primary antiphospholipid syndrome: a pilot study from a single centre in China. Ann Rheum Dis 2021:annrheumdis-2020-219303. [PMID: 33452001 DOI: 10.1136/annrheumdis-2020-219303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Volkov I, Seguro L, Leon EP, Kovács L, Roggenbuck D, Schierack P, Gilburd B, Doria A, Tektonidou MG, Agmon-Levin N. Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome. Auto Immun Highlights 2020;11:8. [PMID: 32467748 DOI: 10.1186/s13317-020-00131-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
286 Uludağ Ö, Çene E, Gurel E, Çetin Ç, Bektaş M, Yalçınkaya Y, Diz-Küçükkaya R, Gül A, Inanç M, Artim-Esen B. Description of damage in different clusters of patients with antiphospholipid syndrome. Lupus 2022;:9612033221079781. [PMID: 35166607 DOI: 10.1177/09612033221079781] [Reference Citation Analysis]
287 Pierangeli SS, Vega-ostertag ME, González EB. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome. Expert Rev Mol Med 2007;9:1-15. [DOI: 10.1017/s1462399407000506] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
288 Yamamoto M, Tabeya T, Naishiro Y, Yajima H, Ishigami K, Shimizu Y, Obara M, Suzuki C, Yamashita K, Yamamoto H. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol. 2012;22:419-425. [PMID: 21953287 DOI: 10.3109/s10165-011-0532-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
289 Cimaz R, Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin North Am 2006;32:553-73. [PMID: 16880084 DOI: 10.1016/j.rdc.2006.05.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
290 Raso S, Sciascia S, Kuzenko A, Castagno I, Marozio L, Bertero MT. Bridging therapy in antiphospholipid syndrome and antiphospholipid antibodies carriers: case series and review of the literature. Autoimmun Rev 2015;14:36-42. [PMID: 25242343 DOI: 10.1016/j.autrev.2014.09.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
291 Rotondi M, Virili C, Pinto S, Coperchini F, Croce L, Brusca N, Centanni M, Chiovato L. The clinical phenotype of Graves' disease occurring as an isolated condition or in association with other autoimmune diseases. J Endocrinol Invest 2020;43:157-62. [PMID: 31407208 DOI: 10.1007/s40618-019-01094-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
292 Ogata Y, Fujieda Y, Sugawara M, Sato T, Ohnishi N, Kono M, Kato M, Oku K, Amengual O, Atsumi T. Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study. Rheumatology (Oxford) 2021;60:1331-7. [PMID: 32944779 DOI: 10.1093/rheumatology/keaa542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
293 Ohnishi N, Fujieda Y, Hisada R, Nakamura H, Kato M, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T. Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome. Rheumatology 2019;58:969-74. [DOI: 10.1093/rheumatology/key340] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
294 Kondo A, Miyamoto T, Yonekawa O, Giessing AM, Østerlund EC, Jensen ON. Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome. Journal of Proteomics 2009;73:123-33. [DOI: 10.1016/j.jprot.2009.08.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
295 Kleinert S, Feuchtenberger M, Tony HP. [Systemic lupus erythematosus. A problem based approach]. Internist (Berl) 2010;51:1013-26; quiz 1027-8. [PMID: 20628717 DOI: 10.1007/s00108-010-2682-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
296 Swadzba J, Sydor WJ, Kolodziejczyk J, Musial J. Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies. Lupus 2014;23:395-9. [PMID: 24474705 DOI: 10.1177/0961203314520841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
297 Zuo Y, Barbhaiya M, Erkan D. Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018? Curr Rheumatol Rep 2018;20. [DOI: 10.1007/s11926-018-0775-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
298 Mac Grory B, Ohman EM, Feng W, Xian Y, Yaghi S, Kamel H, Reznik ME. Advances in the management of cardioembolic stroke associated with patent foramen ovale. BMJ 2022;376:e063161. [PMID: 35140114 DOI: 10.1136/bmj-2020-063161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Pericleous C, Ruiz-Limón P, Romay-Penabad Z, Marín AC, Garza-Garcia A, Murfitt L, Driscoll PC, Latchman DS, Isenberg DA, Giles I, Ioannou Y, Rahman A, Pierangeli SS. Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis. Rheumatology (Oxford) 2015;54:722-7. [PMID: 25273993 DOI: 10.1093/rheumatology/keu360] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
300 Karpouzas GA, Ormseth SR, Hernandez E, Bui VL, Budoff MJ. Beta-2-glycoprotein-I IgA antibodies predict coronary plaque progression in rheumatoid arthritis. Semin Arthritis Rheum 2021;51:20-7. [PMID: 33360226 DOI: 10.1016/j.semarthrit.2020.10.003] [Reference Citation Analysis]
301 Kopytek M, Natorska J, Undas A. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome. Lupus 2017;27:812-9. [DOI: 10.1177/0961203317751644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
302 Khefacha L, Rassas R, Bergaoui H, Mustapha H, Faleh R, Sakly N, Sassi M. Antiphospholipid antibodies in the obstetric antiphospholipid syndrome: Detection and antibodies profile at the Maternity and Neonatal Medicine Center of Monastir, Tunisia. J Obstet Gynaecol Res 2022. [PMID: 35042279 DOI: 10.1111/jog.15143] [Reference Citation Analysis]
303 Kudo M, Lee HL, Yang IA, Masel PJ. Utility of thrombophilia testing in patients with venous thrombo-embolism. J Thorac Dis 2016;8:3697-703. [PMID: 28149566 DOI: 10.21037/jtd.2016.12.40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
304 Soh MC, Nelson-Piercy C, Westgren M, McCowan L, Pasupathy D. Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus? Lupus 2017;26:1351-67. [PMID: 28728509 DOI: 10.1177/0961203317719146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
305 Muscal E, Edwards RM, Kearney DL, Hicks JM, Myones BL, Teruya J. Thrombotic microangiopathic hemolytic anemia with reduction of ADAMTS13 activity: initial manifestation of childhood-onset systemic lupus erythematosus. Am J Clin Pathol 2011;135:406-16. [PMID: 21350095 DOI: 10.1309/AJCP5BVL4FCLCGLU] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
306 Schmoeller DG, Silva BMD, Staub HL. Cocaine abuse, retiform purpura and antiphospholipid syndrome. Rheumatology 2015;54:1533-4. [DOI: 10.1093/rheumatology/kev219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
307 Spinillo A, Beneventi F, Locatelli E, Ramoni V, Caporali R, Alpini C, Albonico G, Cavagnoli C, Montecucco C. The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study. BMC Pregnancy Childbirth 2016;16:313. [PMID: 27756248 DOI: 10.1186/s12884-016-1076-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
308 du Fossé N, van der Hoorn ML, Eikmans M, Heidt S, le Cessie S, Mulders A, van Lith J, Lashley E. Evaluating the role of paternal factors in aetiology and prognosis of recurrent pregnancy loss: study protocol for a hospital-based multicentre case-control study and cohort study (REMI III project). BMJ Open 2019;9:e033095. [PMID: 31727666 DOI: 10.1136/bmjopen-2019-033095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
309 Tincani A, Andreoli L, Casu C, Cattaneo R, Meroni P. Antiphospholipid antibody profile: implications for the evaluation and management of patients. Lupus 2010;19:432-5. [DOI: 10.1177/0961203310361491] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
310 Abisror N, Mekinian A, Lachassinne E, Nicaise-roland P, De Pontual L, Chollet-martin S, Boddaert N, Carbillon L, Fain O. Autism spectrum disorders in babies born to mothers with antiphospholipid syndrome. Seminars in Arthritis and Rheumatism 2013;43:348-51. [DOI: 10.1016/j.semarthrit.2013.07.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
311 Tian J, Casella G, Zhang Y, Rostami A, Li X. Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases. Int J Biol Sci 2020;16:620-32. [PMID: 32025210 DOI: 10.7150/ijbs.39629] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
312 Motoki Y, Nojima J, Yanagihara M, Tsuneoka H, Matsui T, Yamamoto M, Ichihara K. Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells. Thromb Res 2012;130:667-73. [PMID: 22196362 DOI: 10.1016/j.thromres.2011.11.048] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
313 Delesalle C, de Vienne C, Le Hello C, Verspyck E, Dreyfus M. [Antiphospholipid syndrome and pregnancy: Obstetrical prognosis according to the type of APS]. J Gynecol Obstet Biol Reprod (Paris) 2015;44:463-70. [PMID: 25042624 DOI: 10.1016/j.jgyn.2014.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
314 Brezina PR, Kutteh WH. Recurrent Early Pregnancy Loss. In: Falcone T, Hurd WW, editors. Clinical Reproductive Medicine and Surgery. New York: Springer; 2013. pp. 197-208. [DOI: 10.1007/978-1-4614-6837-0_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
315 Zisa D, Goodman SM. Perioperative Management of Rheumatic Disease and Therapies. Med Clin North Am 2021;105:273-84. [PMID: 33589102 DOI: 10.1016/j.mcna.2020.09.011] [Reference Citation Analysis]
316 Hayashi Y, Sasaki H, Suzuki S, Nishiyama T, Kitaori T, Mizutani E, Suzumori N, Sugiura-ogasawara M. Genotyping analyses for polymorphisms of ANXA5 gene in patients with recurrent pregnancy loss. Fertility and Sterility 2013;100:1018-24. [DOI: 10.1016/j.fertnstert.2013.06.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
317 Zheng H, Chen Y, Ao W, Shen Y, Chen XW, Dai M, Wang XD, Yan YC, Yang CD. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Res Ther 2009;11:R93. [PMID: 19545416 DOI: 10.1186/ar2736] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
318 Javaid MM, Grigoriou A, Katsianos D, Kon SP. Nephrotic and anti-phospholipid syndromes: multisystem conditions associated with acute myocardial infarction in young patients. J Ren Care 2012;38:9-14. [PMID: 21917124 DOI: 10.1111/j.1755-6686.2011.00249.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
319 Dietrich JE, Yee DL. Thrombophilic conditions in the adolescent: the gynecologic impact. Obstet Gynecol Clin North Am 2009;36:163-75. [PMID: 19344854 DOI: 10.1016/j.ogc.2008.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
320 Shahin AA, El Desouky SM, Awadallah MY, Megahed DE. Adrenal gland abnormalities detected by magnetic resonance imaging in patients with antiphospholipid syndrome. Z Rheumatol 2017;76:170-5. [PMID: 27307185 DOI: 10.1007/s00393-016-0107-1] [Reference Citation Analysis]
321 Riancho-Zarrabeitia L, Lopez-Marin L, Cacho PM, López-Hoyos M, Barrio RD, Haya A, Martínez-Taboada VM. Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis. Lupus 2022;:9612033221091401. [PMID: 35410552 DOI: 10.1177/09612033221091401] [Reference Citation Analysis]
322 Attia DH, Mokbel A, Haggag HM, Naeem N. Pregnancy outcome in women with active and inactive lupus nephritis: A prospective cohort study. Lupus 2019;28:806-17. [DOI: 10.1177/0961203319846650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
323 Taraborelli M, Erkan D. Pregnancy-Related Challenges in Systemic Autoimmune Diseases. J Infus Nurs 2015;38:360-8. [PMID: 26339942 DOI: 10.1097/NAN.0000000000000124] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
324 Chayoua W, Kelchtermans H, Moore GW, Musiał J, Wahl D, de Laat B, Devreese KMJ. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays. J Thromb Haemost 2018;16:2016-23. [PMID: 30079628 DOI: 10.1111/jth.14261] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
325 Riancho-zarrabeitia L, Cubería M, Muñoz P, López-hoyos M, García-canale S, García-unzueta M, Hernández JL, Martínez-taboada VM. Vitamin D and antiphospholipid syndrome: A retrospective cohort study and meta-analysis. Seminars in Arthritis and Rheumatism 2018;47:877-82. [DOI: 10.1016/j.semarthrit.2017.10.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
326 Hernández-molina G, González-pérez I, Pacheco-molina C, Cabral AR. Quality of life in patients with antiphospholipid syndrome is related to disease burden and anticoagulant therapy. Int J Rheum Dis 2017;20:755-9. [DOI: 10.1111/1756-185x.13045] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
327 Long Y, Li W, Feng J, Ma Y, Sun Y, Xu L, Song Y, Liu C. Follicular helper and follicular regulatory T cell subset imbalance is associated with higher activated B cells and abnormal autoantibody production in primary anti-phospholipid syndrome patients. Clin Exp Immunol 2021. [PMID: 34309827 DOI: 10.1111/cei.13647] [Reference Citation Analysis]
328 Willis R, Cohen H, Giles I, Knight JS, Krilis SA, Rahman A, de Groot PG. Mechanisms of Antiphospholipid Antibody-Mediated Thrombosis. In: Erkan D, Lockshin MD, editors. Antiphospholipid Syndrome. Cham: Springer International Publishing; 2017. pp. 77-116. [DOI: 10.1007/978-3-319-55442-6_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
329 Zhang S, Wu Z, Zhang W, Zhang F, Li Y, Liu Y. Clinical performance of non-criteria antibodies to phospholipids in Chinese patients with antiphospholipid syndrome. Clin Chim Acta 2019;495:205-9. [PMID: 31002781 DOI: 10.1016/j.cca.2019.04.065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
330 Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PLoS Pathog 2021;17:e1010118. [PMID: 34860860 DOI: 10.1371/journal.ppat.1010118] [Reference Citation Analysis]
331 Chaturvedi S, McCrae KR. Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers. Curr Rheumatol Rep 2017;19:43. [PMID: 28711993 DOI: 10.1007/s11926-017-0668-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
332 Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Demoule A, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Combes A, Luyt CE, Amoura Z; SAPHIR study group. CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission. J Autoimmun 2019;103:102292. [PMID: 31253464 DOI: 10.1016/j.jaut.2019.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
333 Demir S, Li J, Magder LS, Petri M. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus. Rheumatology (Oxford) 2021;60:3770-7. [PMID: 33331921 DOI: 10.1093/rheumatology/keaa857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
334 Devreese KM, Pierangeli SS, de Laat B, Tripodi A, Atsumi T, Ortel TL; Subcommittee on Lupus Anticoagulant/Phospholipid/Dependent Antibodies. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. J Thromb Haemost 2014;12:792-5. [PMID: 24589091 DOI: 10.1111/jth.12537] [Cited by in Crossref: 114] [Cited by in F6Publishing: 98] [Article Influence: 16.3] [Reference Citation Analysis]
335 Tsironi E, Gatselis N, Kotoula MG, Zachou K, Pefkianaki M, Zacharaki F, Chatzoulis DZ, Dalekos GN. Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series. Cases J 2009;2:159. [PMID: 19946530 DOI: 10.1186/1757-1626-2-159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
336 dos Santos B, Valverde J, Rohr P, Monticielo O, Brenol J, Xavier R, Chies J. TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from Southern Brazil. Lupus 2012;21:302-9. [DOI: 10.1177/0961203311425522] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
337 Del Porto F, Cifani N, Orgera G, Taurino M, Proietta M. Bilateral spontaneous renal artery dissection and antiphospholipid antibodies. British Journal of Biomedical Science 2020;77:101-4. [DOI: 10.1080/09674845.2019.1708535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
338 Amengual O, Atsumi T, Oku K, Suzuki E, Horita T, Yasuda S, Koike T. Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome. Modern Rheumatology 2014;23:81-8. [DOI: 10.3109/s10165-012-0642-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
339 Kunk PR, Brown J, Mcshane M, Palkimas S, Gail Macik B. Direct oral anticoagulants in hypercoagulable states. J Thromb Thrombolysis 2017;43:79-85. [DOI: 10.1007/s11239-016-1420-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
340 Pal R, Varma S, Ahluwalia J, Prakash G. Antiphospholipid Antibodies Are Not Associated with Clinical Parameters or Prognostic Outcomes in Patients with Non-Hodgkin's Lymphoma. Hamostaseologie 2020;40:662-70. [PMID: 32932545 DOI: 10.1055/a-1223-3367] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
341 Rogenhofer N, Markoff A, Ennerst X, Bogdanova N, Thaler C. Maternal and paternal carriage of the annexin A5 M2 haplotype: a possible risk factor for recurrent implantation failure (RIF). J Assist Reprod Genet 2021;38:235-42. [PMID: 33231792 DOI: 10.1007/s10815-020-01978-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
342 Tedesco F, Borghi MO, Gerosa M, Chighizola CB, Macor P, Lonati PA, Gulino A, Belmonte B, Meroni PL. Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications. Front Immunol 2018;9:1388. [PMID: 29971066 DOI: 10.3389/fimmu.2018.01388] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
343 Davutoğlu EA, Ozel A, Yılmaz N, Madazli R. Pregnancy outcome in 162 women with rheumatic diseases: experience of a university hospital in Turkey. Arch Gynecol Obstet 2017;296:1079-84. [PMID: 28948358 DOI: 10.1007/s00404-017-4535-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
344 Müller C, Thaler M, Schlichtiger A, Schreiegg A, Balling G, Steigerwald U, Luppa PB. β2-glycoprotein I-derived peptides as antigenic structures for the detection of antiphospholipid antibodies. J Thromb Haemost 2010;8:2073-5. [PMID: 20629942 DOI: 10.1111/j.1538-7836.2010.03987.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
345 Caldas CA, de Carvalho JF. Antiphospholipid syndrome and polyarteritis nodosa: a diagnostic and therapeutic challenge. Rheumatol Int 2013;33:2697-8. [PMID: 22833243 DOI: 10.1007/s00296-012-2495-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
346 Ruffatti A, Hoxha A, Favaro M, Tonello M, Colpo A, Cucchini U, Banzato A, Pengo V. Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review. Clin Rev Allergy Immunol 2017;53:28-39. [PMID: 27342460 DOI: 10.1007/s12016-016-8571-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
347 Barbour TD, Crosthwaite A, Chow K, Finlay MJ, Better N, Hughes PD, Cohney SJ. Antiphospholipid syndrome in renal transplantation. Nephrology (Carlton). 2014;19:177-185. [PMID: 24548061 DOI: 10.1111/nep.12217] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
348 Ford HJ, Roubey RA. Pulmonary Manifestations of the Antiphospholipid Antibody Syndrome. Clinics in Chest Medicine 2010;31:537-45. [DOI: 10.1016/j.ccm.2010.05.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
349 Bojalil R, Mazón-González B, Carrillo-Córdova JR, Springall R, Amezcua-Guerra LM. Frequency and clinical significance of a variety of autoantibodies in patients with definite infective endocarditis. J Clin Rheumatol 2012;18:67-70. [PMID: 22334266 DOI: 10.1097/RHU.0b013e318247caf0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
350 Nour-Eldine W, Noureldine HA, Haydar BA, Eldine MN, Noureldine MHA, Uthman I. A glimpse into the history of description of the antiphospholipid syndrome. Lupus 2020;29:1493-502. [PMID: 32741306 DOI: 10.1177/0961203320947152] [Reference Citation Analysis]
351 Mahler M, Albesa R, Zohoury N, Bertolaccini ML, Ateka-Barrutia O, Rodriguez-Garcia JL, Norman GL, Khamashta M. Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome. Lupus 2016;25:911-6. [PMID: 27252269 DOI: 10.1177/0961203316640366] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
352 Dienava-Verdoold I, Boon-Spijker MG, de Groot PG, Brinkman HJ, Voorberg J, Mertens K, Derksen RH, de Laat B. Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity. J Thromb Haemost 2011;9:738-47. [PMID: 21255251 DOI: 10.1111/j.1538-7836.2011.04212.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
353 Tincani A, Andreoli L, Chighizola C, Meroni PL, Tincani A, Andreoli L, Chighizola C, Meroni PL. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Autoimmunity 2009;42:257-9. [DOI: 10.1080/08916930902827918] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
354 Saponjski J, Stojanovich L, Saponjski J, Mirilovic M, Saponjski D. Abdominal pain in patient with antiphospholipid syndrome-the role of MDCT angiography on visceral blood vessels. Immunol Res 2017;65:1150-5. [PMID: 29134567 DOI: 10.1007/s12026-017-8968-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
355 de Laat B, de Groot PG. Autoantibodies directed against domain I of beta2-glycoprotein I. Curr Rheumatol Rep 2011;13:70-6. [PMID: 21046294 DOI: 10.1007/s11926-010-0144-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
356 Borella E, Lojacono A, Gatto M, Andreoli L, Taglietti M, Iaccarino L, Casiglia E, Punzi L, Tincani A, Doria A. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res 2014;60:170-6. [DOI: 10.1007/s12026-014-8572-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
357 Alibaz-Oner F, Ergelen R, Yıldız Y, Aldag M, Yazici A, Cefle A, Koç E, Artım Esen B, Mumcu G, Ergun T, Direskeneli H. Femoral vein wall thickness measurement: A new diagnostic tool for Behçet's disease. Rheumatology (Oxford) 2021;60:288-96. [PMID: 32756998 DOI: 10.1093/rheumatology/keaa264] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
358 McQueen DB, Perfetto CO, Hazard FK, Lathi RB. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril 2015;104:927-31. [PMID: 26207958 DOI: 10.1016/j.fertnstert.2015.06.044] [Cited by in Crossref: 91] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
359 Rand JH, Wu XX, Quinn AS, Chen PP, Hathcock JJ, Taatjes DJ. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers. Blood 2008;112:1687-95. [PMID: 18577708 DOI: 10.1182/blood-2008-03-144204] [Cited by in Crossref: 152] [Cited by in F6Publishing: 119] [Article Influence: 10.9] [Reference Citation Analysis]
360 Teke HÜ, Cansu DÜ, Korkmaz C. Detailed features of hematological involvement and medication-induced cytopenia in systemic lupus erythematosus patients: single center results of 221 patients. Eur J Rheumatol 2017;4:87-92. [PMID: 28638678 DOI: 10.5152/eurjrheum.2017.160086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
361 Klonizakis P, Tselios K, Sarantopoulos A, Gougourellas I, Rouka E, Onufriadou Z, Kapali P, Kyriakou D, Boura P. ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status? Lupus. 2013;22:443-452. [PMID: 23554033 DOI: 10.1177/0961203313477898] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
362 Joste V, Dragon-durey M, Darnige L. Diagnostic biologique du syndrome des antiphospholipides : des critères à la pratique. La Revue de Médecine Interne 2018;39:34-41. [DOI: 10.1016/j.revmed.2017.02.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
363 Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev 2010;10:74-9. [PMID: 20696282 DOI: 10.1016/j.autrev.2010.08.005] [Cited by in Crossref: 106] [Cited by in F6Publishing: 66] [Article Influence: 8.8] [Reference Citation Analysis]
364 Gelosa G, Tremolizzo L, Galbussera A, Perego R, Capra M, Frigo M, Apale P, Ferrarese C, Appollonio I. Narrowing the window for ‘senile chorea’: A case with primary antiphospholipid syndrome. Journal of the Neurological Sciences 2009;284:211-3. [DOI: 10.1016/j.jns.2009.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
365 Savelli SL, Roubey RAS, Kitzmiller KJ, Zhou D, Nagaraja HN, Mulvihill E, Barbar-Smiley F, Ardoin SP, Wu YL, Yu CY. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL). Front Immunol. 2019;10:885. [PMID: 31134052 DOI: 10.3389/fimmu.2019.00885] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
366 Eid MI, Abdelhafez MS, El-Refaie W, El-Zayadi AA, Samir K, Abdelrazik MM, Thabet M, Wageh A, Fyala EA, Abdeldayem Y, Badawy A. Timing of initiation of low-molecular-weight heparin administration in pregnant women with antiphospholipid syndrome: a randomized clinical trial of efficacy and safety. Int J Womens Health 2019;11:41-7. [PMID: 30666167 DOI: 10.2147/IJWH.S193293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
367 Kaneshige R, Nojima J, Motoki Y, Tsuneoka H. aCL/β2GPI and aPS/PT show synergic thrombogenic effects in suppressing anticoagulant activity of APC and stimulating tissue factor expression and TNF-α secretion by mononuclear cells. Thromb Res 2019;181:52-8. [PMID: 31351266 DOI: 10.1016/j.thromres.2019.07.006] [Reference Citation Analysis]
368 Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384:1878-1888. [PMID: 24881804 DOI: 10.1016/s0140-6736(14)60128-8] [Cited by in Crossref: 383] [Cited by in F6Publishing: 181] [Article Influence: 47.9] [Reference Citation Analysis]
369 Cheldieva FA, Reshetnyak TM, Cherkasova MV, Lila AM. Study of antiphospholipid antibodies by enzyme immunoassay and chemiluminescent methods in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data). Klin Lab Diagn 2021;66:546-51. [PMID: 34543533 DOI: 10.51620/0869-2084-2021-66-9-546-551] [Reference Citation Analysis]
370 Islam MA. Antiphospholipid antibodies and antiphospholipid syndrome in cancer: Uninvited guests in troubled times. Semin Cancer Biol 2020;64:108-13. [PMID: 31351197 DOI: 10.1016/j.semcancer.2019.07.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
371 Sthoeger Z, Sharabi A, Asher I, Zinger H, Segal R, Shearer G, Elkayam O, Mozes E. The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients. Clinical Immunology 2018;192:85-91. [DOI: 10.1016/j.clim.2018.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
372 Agmon-Levin N, Rosário C, Katz BS, Zandman-Goddard G, Meroni P, Cervera R, Stojanovich L, Blank M, Pierangeli S, Praprotnik S, Meis Ed, Seguro LP, Ruffatti A, Pengo V, Tincani A, Doria A, Shoenfeld Y. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). Lupus 2013;22:1327-35. [PMID: 24036580 DOI: 10.1177/0961203313504633] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
373 Su BY, Su CY, Yu SF, Chen CJ. Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol 2007;196:165-70. [PMID: 17318574 DOI: 10.1007/s00430-007-0040-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
374 Perés Wingeyer S, Aranda F, Udry S, Latino J, de Larrañaga G. Trombofilia hereditaria y pérdidas de embarazo. Estudio de una cohorte de Argentina. Medicina Clínica 2019;152:249-54. [DOI: 10.1016/j.medcli.2017.12.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
375 Muthu S, Chellamuthu G, Gopalsamy TP, Kandasamy V. Secondary Erosive Arthritis in a Young Lady - A Rare Manifestation of Primary Antiphospholipid Antibody Syndrome. J Orthop Case Rep 2021;11:15-8. [PMID: 34141662 DOI: 10.13107/jocr.2021.v11.i02.2006] [Reference Citation Analysis]
376 Benjamin LA, Paterson RW, Moll R, Pericleous C, Brown R, Mehta PR, Athauda D, Ziff OJ, Heaney J, Checkley AM, Houlihan CF, Chou M, Heslegrave AJ, Chandratheva A, Michael BD, Blennow K, Vivekanandam V, Foulkes A, Mummery CJ, Lunn MP, Keddie S, Spyer MJ, Mckinnon T, Hart M, Carletti F, Jäger HR, Manji H, Zandi MS, Werring DJ, Nastouli E, Simister R, Solomon T, Zetterberg H, Schott JM, Cohen H, Efthymiou M; UCLH Queen Square COVID-19 Biomarker Study group. Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study. EClinicalMedicine 2021;:101070. [PMID: 34401683 DOI: 10.1016/j.eclinm.2021.101070] [Reference Citation Analysis]
377 Hübbe-Tena C, Gallegos-Nava S, Márquez-Velasco R, Castillo-Martínez D, Vargas-Barrón J, Sandoval J, Amezcua-Guerra LM. Pulmonary hypertension in systemic lupus erythematosus: echocardiography-based definitions predict 6-year survival. Rheumatology (Oxford) 2014;53:1256-63. [PMID: 24599923 DOI: 10.1093/rheumatology/keu012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
378 Krilis M, Qi M, Ioannou Y, Zhang JY, Ahmadi Z, Wong JWH, Vlachoyiannopoulos PG, Moutsopoulos HM, Koike T, Sturgess AD, Chong BH, Krilis SA, Giannakopoulos B. Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk. J Autoimmun 2021;122:102675. [PMID: 34098405 DOI: 10.1016/j.jaut.2021.102675] [Reference Citation Analysis]
379 Yamada H, Atsumi T, Amengual O, Koike T, Furuta I, Ohta K, Kobashi G. Anti-beta2 glycoprotein-I antibody increases the risk of pregnancy-induced hypertension: a case-controlled study. J Reprod Immunol 2010;84:95-9. [PMID: 20004024 DOI: 10.1016/j.jri.2009.10.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
380 Poulton K, Ripoll VM, Pericleous C, Meroni PL, Gerosa M, Ioannou Y, Rahman A, Giles IP. Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion. Am J Reprod Immunol 2015;73:390-401. [PMID: 25469631 DOI: 10.1111/aji.12341] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
381 Pregnolato F, Gerosa M, Raimondo MG, Comerio C, Bartoli F, Lonati PA, Borghi MO, Acaia B, Ossola MW, Ferrazzi E, Trespidi L, Meroni PL, Chighizola CB. EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies. Rheumatology (Oxford) 2021;60:1114-24. [PMID: 32441742 DOI: 10.1093/rheumatology/keaa203] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
382 Aakre KM, Langlois MR, Watine J, Barth JH, Baum H, Collinson P, Laitinen P, Oosterhuis WP. Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation. Clin Chem Lab Med 2013;51:1217-26. [PMID: 23037517 DOI: 10.1515/cclm-2012-0574] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
383 Lefèvre G, Lambert M, Bacri JL, Dubucquoi S, Quemeneur T, Caron C, Launay D, Houfflin-Debarge V, Hachulla E, Kyndt X, Subtil D, Hatron PY. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients. Lupus 2011;20:861-5. [PMID: 21546412 DOI: 10.1177/0961203310397080] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
384 Meijer K, Schulman S. The absence of `minor' risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios. Journal of Thrombosis and Haemostasis 2009;7:1619-28. [DOI: 10.1111/j.1538-7836.2009.03557.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
385 Oke V, Brauner S, Larsson A, Gustafsson J, Zickert A, Gunnarsson I, Svenungsson E. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE). Arthritis Res Ther 2017;19:139. [PMID: 28619037 DOI: 10.1186/s13075-017-1344-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
386 Elbagir S, Elshafie AI, Elagib EM, Mohammed NA, Aledrissy MI, Manivel VA, Pertsinidou E, Nur MA, Gunnarsson I, Svenungsson E, Rönnelid J. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients. Lupus 2020;29:1412-22. [PMID: 32741301 DOI: 10.1177/0961203320945387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
387 Gkrouzman E, Barbhaiya M, Erkan D, Lockshin MD. Reality Check on Antiphospholipid Antibodies in COVID‐19–Associated Coagulopathy. Arthritis Rheumatol 2021;73:173-4. [DOI: 10.1002/art.41472] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 8.5] [Reference Citation Analysis]
388 Serrano M, Morán L, Martinez-Flores JA, Mancebo E, Pleguezuelo D, Cabrera-Marante O, Delgado J, Serrano A. Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation. Front Immunol 2019;10:2891. [PMID: 31921152 DOI: 10.3389/fimmu.2019.02891] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
389 Saison J, Costedoat-chalumeau N, Maucort-boulch D, Iwaz J, Marignier R, Cacoub P, Vital-durand D, Hot A, Tebib J, Aumaitre O, Schleinitz N, Sarrot-reynauld F, Broussolle C, Sève P. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients. Lupus 2015;24:74-81. [DOI: 10.1177/0961203314547795] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
390 Basu R, De Hazra O, Mondal S, Ghosh S, Ghosh S. Parotid swelling due to external carotid artery thrombus-a rare manifestation in antiphospholipid syndrome. Oxf Med Case Reports 2019;2019:omz052. [PMID: 31281662 DOI: 10.1093/omcr/omz052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
391 Klumb EM, Silva CAA, Lanna CCD, Sato EI, Borba EF, Brenol JCT, Albuquerque EMDND, Monticielo OA, Costallat LTL, Latorre LC, Sauma MDFLDC, Bonfá ESDDO, Ribeiro FM. Consenso da Sociedade Brasileira de Reumatologia para o diagnóstico, manejo e tratamento da nefrite lúpica. Revista Brasileira de Reumatologia 2015;55:1-21. [DOI: 10.1016/j.rbr.2014.09.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
392 Bećarević M, Sarić M, Stojanovich L, Mirković D, Dopsaj V, Ignjatović S. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome. Clin Rheumatol 2018;37:3359-64. [PMID: 29948348 DOI: 10.1007/s10067-018-4170-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
393 Du VX, Kelchtermans H, de Groot PG, de Laat B. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: Pathogenic mechanisms of the antiphospholipid syndrome. Thrombosis Research 2013;132:319-26. [DOI: 10.1016/j.thromres.2013.07.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
394 Miyaji M, Deguchi M, Tanimura K, Sasagawa Y, Morizane M, Ebina Y, Yamada H. Clinical factors associated with pregnancy outcome in women with recurrent pregnancy loss. Gynecological Endocrinology 2019;35:913-8. [DOI: 10.1080/09513590.2019.1604657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
395 Khamashta MA, Amigo M. Antiphospholipid syndrome. Rheumatology. Elsevier; 2015. pp. 1144-52. [DOI: 10.1016/b978-0-323-09138-1.00139-x] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
396 Yu A, Stephens D, Feldman BM, Parkin PC, Kahr WH, Brandão LR, Shouldice M, Levin AV. The role of prothrombotic factors in the ocular manifestations of abusive and non-abusive head trauma: a feasibility study. Child Abuse Negl 2012;36:333-41. [PMID: 22575907 DOI: 10.1016/j.chiabu.2011.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
397 Trenor CC, Michelson AD. Thrombophilia and Pediatric Stroke. Circulation 2010;121:1795-7. [DOI: 10.1161/cir.0b013e3181df6410] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
398 Jansen AFM, Raijmakers RPH, Keijmel SP, van der Molen RG, Vervoort GM, van der Meer JWM, van Deuren M, Bleeker-Rovers CP. Autoimmunity and B-cell dyscrasia in acute and chronic Q fever: A review of the literature. Eur J Intern Med 2018;54:6-12. [PMID: 29908707 DOI: 10.1016/j.ejim.2018.06.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
399 Goldhaber SZ, Eriksson H, Kakkar A, Schellong S, Feuring M, Fraessdorf M, Kreuzer J, Schueler E, Schulman S. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER ® , RE-COVER™ II, and RE-MEDY™. Vasc Med 2016;21:506-14. [DOI: 10.1177/1358863x16668588] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 6.2] [Reference Citation Analysis]
400 Misasi R, Longo A, Recalchi S, Caissutti D, Riitano G, Manganelli V, Garofalo T, Sorice M, Capozzi A. Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS". Int J Mol Sci 2020;21:E8411. [PMID: 33182499 DOI: 10.3390/ijms21218411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
401 Manukyan D, Rossmann H, Schulz A, Zeller T, Pfeiffer N, Binder H, Münzel T, Beutel ME, Müller-Calleja N, Wild PS, Lackner KJ. Distribution of antiphospholipid antibodies in a large population-based German cohort. Clin Chem Lab Med 2016;54:1663-70. [PMID: 27028736 DOI: 10.1515/cclm-2016-0014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
402 García Palacios JD, Puente Ruiz N, Napal Lecumberri JJ, Hernández Hernández JL. [Effects of the COVID-19 pandemic on a cohort of patients with vein occlusion]. Rev Clin Esp 2021. [PMID: 34248175 DOI: 10.1016/j.rce.2021.06.001] [Reference Citation Analysis]
403 Khattri S, Zandman-goddard G, Peeva E. B-cell directed therapies in antiphospholipid antibody syndrome — New directions based on murine and human data. Autoimmunity Reviews 2012;11:717-22. [DOI: 10.1016/j.autrev.2011.12.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
404 de Laat B, Pengo V, Pabinger I, Musial J, Voskuyl AE, Bultink IE, Ruffatti A, Rozman B, Kveder T, de Moerloose P, Boehlen F, Rand J, Ulcova-Gallova Z, Mertens K, de Groot PG. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 2009;7:1767-73. [PMID: 19694946 DOI: 10.1111/j.1538-7836.2009.03588.x] [Cited by in Crossref: 199] [Cited by in F6Publishing: 180] [Article Influence: 15.3] [Reference Citation Analysis]
405 Check JH. The Use of Heparin for Preventing Miscarriage. Am J Reprod Immunol 2012;67:326-33. [DOI: 10.1111/j.1600-0897.2012.01119.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
406 Hou S, Harper PE, Bardin N, Zhao M. The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine. J Immunol Methods 2017;440:27-34. [PMID: 27784626 DOI: 10.1016/j.jim.2016.10.005] [Reference Citation Analysis]
407 Tumian NR, Hunt BJ. Clinical Management of Thrombotic Antiphospholipid Syndrome. JCM 2022;11:735. [DOI: 10.3390/jcm11030735] [Reference Citation Analysis]
408 Alchi B, Griffiths M, Jayne D. What nephrologists need to know about antiphospholipid syndrome. Nephrol Dial Transplant 2010;25:3147-54. [PMID: 20587422 DOI: 10.1093/ndt/gfq356] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
409 Ząbczyk M, Meus R, Malinowski KP, Natorska J, Undas A. A Prothrombotic State in Patients With a History of Left Ventricular Thrombus. Am J Cardiol 2019;123:1358-63. [PMID: 30717886 DOI: 10.1016/j.amjcard.2019.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
410 Nacinovich R, Galli J, Bomba M, Filippini E, Parrinello G, Nuzzo M, Lojacono A, Motta M, Tincani A. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum 2008;59:345-51. [DOI: 10.1002/art.23311] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
411 Misasi R, Capozzi A, Longo A, Recalchi S, Lococo E, Alessandri C, Conti F, Valesini G, Sorice M. "New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome. J Immunol Res 2015;2015:858542. [PMID: 25874238 DOI: 10.1155/2015/858542] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
412 Meus R, Son M, Sobczyk D, Undas A. Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events. Stroke 2016;47:1872-8. [PMID: 27301942 DOI: 10.1161/STROKEAHA.116.012856] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
413 Saito M, Makino Y, Inoue K, Watanabe Y, Hoshi O, Kubota T. Anti-DNA antibodies cross-reactive with β2-glycoprotein I induce monocyte tissue factor through the TLR9 pathway. Immunol Med 2021;44:124-35. [PMID: 32701417 DOI: 10.1080/25785826.2020.1796285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
414 Folkeringa N, Brouwer JLP, Korteweg FJ, Veeger NJGM, Erwich JJHM, Holm JP, van der Meer J. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol 2007;136:656-61. [DOI: 10.1111/j.1365-2141.2006.06480.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
415 Meyer MR, Witt DM, Delate T, Johnson SG, Fang M, Go A, Clark NP. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. Thromb Res 2015;136:1160-4. [PMID: 26477821 DOI: 10.1016/j.thromres.2015.10.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
416 Ho DK, Ramessur R, Gupta M, Mathews JP. Homonymous hemianopia in the primary antiphospholipid syndrome. BMJ Case Rep 2017;2017:bcr2016218660. [PMID: 28179389 DOI: 10.1136/bcr-2016-218660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
417 Alba P, Gómez-puerta JA, Goycochea-robles MV, Amigo MC. Organ Damage and Quality of Life in Antiphospholipid Syndrome. Curr Rheumatol Rep 2016;18. [DOI: 10.1007/s11926-015-0556-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
418 Del Ross T, Ruffatti A, Visentin MS, Tonello M, Calligaro A, Favaro M, Hoxha A, Punzi L. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study. J Rheumatol 2013;40:425-9. [PMID: 23418380 DOI: 10.3899/jrheum.120576] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
419 Suárez-Pérez L, Coto-Hernández R, Suárez-Cuervo C, Caminal-Montero L. Reply to "High frequency of Antiphospholipid Antibodies in Critically ill COVID-19 patients: a Link with Hypercoagulability?". J Intern Med 2021;289:425-6. [PMID: 32909292 DOI: 10.1111/joim.13159] [Reference Citation Analysis]
420 Forastiero R. Bleeding in the antiphospholipid syndrome. Hematology 2012;17:s153-5. [DOI: 10.1179/102453312x13336169156654] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
421 Park YH. Diagnosis and management of thrombocytopenia in pregnancy. Blood Res 2022;57:79-85. [PMID: 35483931 DOI: 10.5045/br.2022.2022068] [Reference Citation Analysis]
422 Weeding E, Coit P, Yalavarthi S, Kaplan MJ, Knight JS, Sawalha AH. Genome-wide DNA methylation analysis in primary antiphospholipid syndrome neutrophils. Clin Immunol 2018;196:110-6. [PMID: 30471352 DOI: 10.1016/j.clim.2018.11.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
423 Meneghel L, Ruffatti A, Gavasso S, Tonello M, Mattia E, Spiezia L, Tormene D, Hoxha A, Fedrigo M, Simioni P. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome. Clinica Chimica Acta 2015;446:201-5. [DOI: 10.1016/j.cca.2015.04.033] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
424 Rastogi P, Kumar N, Ahluwalia J, Das R, Varma N, Suri V, Senee H. Thrombophilic risk factors are laterally associated with Apolipoprotein E gene polymorphisms in deep vein thrombosis patients: An Indian study. Phlebology 2019;34:324-35. [PMID: 30282515 DOI: 10.1177/0268355518802693] [Reference Citation Analysis]
425 Efthymiou M, Lawrie AS, Mackie I, Arachchillage D, Lane PJ, Machin S, Cohen H. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome. Thrombosis Research 2015;135:1191-7. [DOI: 10.1016/j.thromres.2015.03.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
426 Castro-Gutierrez A, Young K, Bermas BL. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. Rheum Dis Clin North Am 2022;48:523-35. [PMID: 35400376 DOI: 10.1016/j.rdc.2022.02.009] [Reference Citation Analysis]
427 Sénant M, Rostane H, Fernani-Oukil F, Hosking F, Bellery F, Courchinoux A, Tartour E, Darnige L, Dragon-Durey MA. Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay. J Immunol Res 2015;2015:983094. [PMID: 26065010 DOI: 10.1155/2015/983094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
428 Zuo Y, Shi H, Li C, Knight JS. Antiphospholipid syndrome: a clinical perspective. Chin Med J (Engl) 2020;133:929-40. [PMID: 32265421 DOI: 10.1097/CM9.0000000000000705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
429 Branger S, Schleinitz N, Veit V, Martaresche C, Bourlière M, Roblin X, Garcia S, San Marco M, Camoin L, Durand J, Harlé J. Étude de l'association hépatite auto-immune et antiphospholipides. La Revue de Médecine Interne 2007;28:218-24. [DOI: 10.1016/j.revmed.2006.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
430 Drosos GC, Konstantonis G, Sfikakis PP, Tektonidou MG. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus. Eur J Prev Cardiolog. [DOI: 10.1177/2047487320906650] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
431 Ioannou Y, Zhang JY, Qi M, Gao L, Qi JC, Yu DM, Lau H, Sturgess AD, Vlachoyiannopoulos PG, Moutsopoulos HM, Rahman A, Pericleous C, Atsumi T, Koike T, Heritier S, Giannakopoulos B, Krilis SA. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I. Arthritis Rheum 2011;63:2774-82. [PMID: 21618459 DOI: 10.1002/art.30383] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
432 Hisada R, Kato M, Sugawara E, Kanda M, Fujieda Y, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T. Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation. J Thromb Haemost 2019;17:1134-43. [DOI: 10.1111/jth.14427] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
433 Stern C, Trapp E, Mautner E, Deutsch M, Lang U, Cervar-zivkovic M. The impact of severe preeclampsia on maternal quality of life. Qual Life Res 2014;23:1019-26. [DOI: 10.1007/s11136-013-0525-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
434 Simchen MJ, Dulitzki M, Rofe G, Shani H, Langevitz P, Schiff E, Pauzner R. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome. Acta Obstet Gynecol Scand 2011;90:1428-33. [PMID: 21729009 DOI: 10.1111/j.1600-0412.2011.01236.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
435 Aoki J, Uchino K. Treatment of risk factors to prevent stroke. Neurotherapeutics 2011;8:463-74. [PMID: 21713592 DOI: 10.1007/s13311-011-0054-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
436 Meroni P, Chighizola C. Pathophysiology of the antiphospholipid syndrome (APS). La Revue de Médecine Interne 2012;33:A2-4. [DOI: 10.1016/j.revmed.2012.09.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
437 Marinho JL, Piovesan EJ, Leite Neto MP, Kotze LR, Noronha Ld, Twardowschy CA, Lange MC, Scola RH, Zétola VH, Nóvak EM, Werneck LC. Clinical, neurovascular and neuropathological features in Sneddon's syndrome. Arq Neuropsiquiatr 2007;65:390-5. [PMID: 17665002 DOI: 10.1590/s0004-282x2007000300005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
438 Crowley MP, Cuadrado MJ, Hunt BJ. Catastrophic antiphospholipid syndrome on switching from warfarin to rivaroxaban. Thrombosis Research 2017;153:37-9. [DOI: 10.1016/j.thromres.2017.03.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
439 Demarchi J, Papasidero SB, Klajn D, Alba P, Babini AM, Durigan V, Gobbi C, Raiti L. Primary Sjögren's syndrome and pregnancy: A report of 18 cases. Reumatol Clin (Engl Ed) 2019;15:109-12. [PMID: 28844688 DOI: 10.1016/j.reuma.2017.07.014] [Reference Citation Analysis]
440 Rand JH, Wu XX, Wolgast LR, Lei V, Conway EM. A novel 2-stage approach that detects complement activation in patients with antiphospholipid antibody syndrome. Thromb Res 2017;156:119-25. [PMID: 28628799 DOI: 10.1016/j.thromres.2017.06.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
441 Becker YL, Julien AS, Godbout A, Boilard É, Fortin PR. Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome. Lupus 2020;29:1623-9. [PMID: 32787553 DOI: 10.1177/0961203320944481] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
442 Giles I, Lambrianides A, Rahman A. Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function. Lupus 2008;17:895-903. [DOI: 10.1177/0961203308091541] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
443 Gary T, Belaj K, Bruckenberger R, Hackl G, Hafner F, Froehlich H, Zebisch A, Pilger E, Brodmann M. Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism: PAPS in Overweight and Obese VTE-Patients. Obesity 2013;21:E463-6. [DOI: 10.1002/oby.20188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
444 Bettacchioli E, Le Gaffric C, Mazeas M, Borghi MO, Frostegard J, Barturen G, Makowska Z, Babei S, Lesche R, Meroni PL, Alarcon-Riquelme ME, Renaudineau Y; PRECISESADS Clinical Consortium. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases. J Transl Autoimmun 2021;4:100090. [PMID: 33817614 DOI: 10.1016/j.jtauto.2021.100090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
445 Katikireddi VS, Kandiah DA. Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy: Brief Communication. Internal Medicine Journal 2012;42:585-91. [DOI: 10.1111/j.1445-5994.2012.02768.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
446 Danza Á, Ruiz-Irastorza G, Khamashta M. [Pregnancy in systemic autoimmune diseases: Myths, certainties and doubts]. Med Clin (Barc) 2016;147:306-12. [PMID: 27143525 DOI: 10.1016/j.medcli.2016.03.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
447 Urbanus RT, de Laat B. Antiphospholipid antibodies and the protein C pathway. Lupus. 2010;19:394-399. [PMID: 20353976 DOI: 10.1177/0961203309360841] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
448 Marlar RA, Husain S. The enigmas of the lupus anticoagulant: mechanisms, diagnosis, and management. Curr Rheumatol Rep. 2008;10:74-80. [PMID: 18457616 DOI: 10.1007/s11926-008-0013-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
449 Zuily S, Wahl D. Pulmonary Hypertension in Antiphospholipid Syndrome. Curr Rheumatol Rep 2015;17. [DOI: 10.1007/s11926-014-0478-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
450 Appelgren D, Dahle C, Knopf J, Bilyy R, Vovk V, Sundgren PC, Bengtsson AA, Wetterö J, Muñoz LE, Herrmann M, Höög A, Sjöwall C. Active NET formation in Libman–Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus. Autoimmunity 2018;51:310-8. [DOI: 10.1080/08916934.2018.1514496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
451 Heil JW, Malinowski L, Rinderknecht A, Broderick JP, Franz D. Use of Intravenous Tissue Plasminogen Activator in a 16-Year-Old Patient with Basilar Occlusion. J Child Neurol 2008;23:1049-53. [DOI: 10.1177/0883073808319076] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
452 Miyara M, Diemert M, Amoura Z, Musset L. Anticorps antiphospholipides en pratique. La Revue de Médecine Interne 2012;33:176-80. [DOI: 10.1016/j.revmed.2011.09.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
453 Keiserman B, Ronchetti MR, Monticielo OA, Keiserman MW, Staub HL. Concomitance of IgM and IgG anti-dsDNA Antibodies Does Not Appear to Associate to Active Lupus Nephritis. Open Rheumatol J 2013;7:101-4. [PMID: 24358068 DOI: 10.2174/1874312901307010101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
454 Barron N, Arenas-Osuna J, Medina G, Cruz-Dominguez MP, González-Romero F, Velásques-García JA, Ayala-López EA, Jara LJ. Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis. Clin Rheumatol 2018;37:943-8. [PMID: 29335897 DOI: 10.1007/s10067-018-3979-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
455 Ruffatti A, Calligaro A, Del Ross T, Favaro M, Tonello M, Banzato A, Punzi L, Pengo V. Risk-based secondary prevention of obstetric antiphospholipid syndrome. Lupus 2012;21:741-3. [DOI: 10.1177/0961203312446388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
456 Singh NK, Gupta A, Behera DR, Dash D. Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome. Rheumatol Int 2013;33:2331-6. [PMID: 23519427 DOI: 10.1007/s00296-013-2717-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
457 Dargaud Y, Rugeri L, Vergnes MC, Arnuti B, Miranda P, Negrier C, Bestion A, Desmurs-clavel H, Ninet J, Gaucherand P, Rudigoz RC, Berland M, Champion F, Trzeciak MC. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study. British Journal of Haematology 2009;145:825-35. [DOI: 10.1111/j.1365-2141.2009.07698.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
458 Middeldorp S, Naue C, Köhler C. Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom? Hamostaseologie 2022;42:54-64. [PMID: 35196731 DOI: 10.1055/a-1717-7663] [Reference Citation Analysis]
459 Gustafsson JT, Gunnarsson I, Källberg H, Pettersson S, Zickert A, Vikerfors A, Möller S, Rönnelid J, Elvin K, Svenungsson E. Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus. Ann Rheum Dis 2015;74:1537-43. [PMID: 24692586 DOI: 10.1136/annrheumdis-2013-205159] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
460 Hoxha A, Ruffatti A, Pittoni M, Bontadi A, Tonello M, Salvan E, Plebani M, Punzi L. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clinica Chimica Acta 2012;413:911-3. [DOI: 10.1016/j.cca.2012.02.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
461 Monahan RC, Inglese F, Middelkoop H, van Buchem M, Huizinga TW, Kloppenburg M, Ronen I, Steup-Beekman GM, de Bresser J. White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms. RMD Open 2021;7:e001650. [PMID: 34321253 DOI: 10.1136/rmdopen-2021-001650] [Reference Citation Analysis]
462 Rosa RF, Ugolini-Lopes MR, Gandara APR, Vendramini MBG, Campanholo KR, Dutra L, de Andrade DCO. Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS). Rheumatology (Oxford) 2021;60:179-87. [PMID: 32613245 DOI: 10.1093/rheumatology/keaa252] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Bloemen S, Wu XX, Devreese KM, de Laat B, Rand JH, Vasovic LV. Inverted erythrocyte membranes demonstrate β2GPI-antiphospholipid antibody interactions and membrane crosslinking. Thromb Res 2016;146:89-94. [PMID: 27622308 DOI: 10.1016/j.thromres.2016.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
464 Wind M, Hendriks M, van Brussel BTJ, Eikenboom J, Allaart CF, Lamb HJ, Siebelink HJ, Ninaber MK, van Geloven N, van Lith JMM, Huizinga TWJ, Rabelink TJ, Sueters M, Teng YKO. Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome. Lupus Sci Med 2021;8:e000472. [PMID: 33952625 DOI: 10.1136/lupus-2020-000472] [Reference Citation Analysis]
465 McDonnell TCR, Willis R, Pericleous C, Ripoll VM, Giles IP, Isenberg DA, Brasier AR, Gonzalez EB, Papalardo E, Romay-Penabad Z, Jamaluddin M, Ioannou Y, Rahman A. PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome. Front Immunol 2018;9:2413. [PMID: 30405613 DOI: 10.3389/fimmu.2018.02413] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
466 Lu X, Liu Z, Zhang X, Kang X, Shen W, Zhao A. Prothrombotic state of patients with unexplained recurrent spontaneous abortion. Int J Gynaecol Obstet 2015;131:161-5. [PMID: 26296564 DOI: 10.1016/j.ijgo.2015.04.049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
467 Tripodi A. Testing for lupus anticoagulants: all that a clinician should know. Lupus 2009;18:291-8. [PMID: 19276296 DOI: 10.1177/0961203308101436] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
468 Maher L, Perugino C. Diagnostic Pitfalls in Immunology Testing. Clinics in Laboratory Medicine 2019;39:567-78. [DOI: 10.1016/j.cll.2019.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
469 de Jesus GR, Agmon-Levin N, Andrade CA, Andreoli L, Chighizola CB, Porter TF, Salmon J, Silver RM, Tincani A, Branch DW. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev 2014;13:795-813. [PMID: 24650941 DOI: 10.1016/j.autrev.2014.02.003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 102] [Article Influence: 15.8] [Reference Citation Analysis]
470 Bao SH, Wang XP, Lin QD, Di W, Xu L, Ding CW. The Investigation on the Value of Repeat and Combination Test of ACA and Anti-β2-GPI Antibody in Women with Recurrent Spontaneous Abortion: ACA AND ANTI-β2-GPI ANTIBODIES IN RSA. American Journal of Reproductive Immunology 2008;60:372-8. [DOI: 10.1111/j.1600-0897.2008.00638.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
471 Yevtushenko SK, Filimonov DA, Yevtushenko IS. New risk factors of stroke in young adults. Z nevrol psikhiatr im S S Korsakova 2015;115:3. [DOI: 10.17116/jnevro20151151223-12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
472 Vikerfors A, Svenungsson E, Ågren A, Mobarrez F, Bremme K, Holmström M, Eelde A, Bruzelius M, Elgue G, Wallén H, Antovic A. Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome. Thrombosis Research 2014;133:936-44. [DOI: 10.1016/j.thromres.2014.02.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
473 Serrano R, Pons-Estel GJ, Espinosa G, Quintana RM, Reverter JC, Tassies D, Monteagudo J, Cervera R. Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center. Lupus 2020;29:1050-9. [PMID: 32536318 DOI: 10.1177/0961203320933009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
474 Boffa MC, Lachassinne E, Boinot C, De Carolis S, Rovere-Querini P, Avcin T, Biasini-Rebaioli C, Le Toumelin P, Aurousseau MH, Tincani A. European registry of babies born to mothers with antiphospholipid syndrome: a result update. Lupus 2009;18:900-4. [PMID: 19671790 DOI: 10.1177/0961203309106951] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
475 Weng C, Chung T, Liu M, Weng M, Lee C, Chen J, Wu A, Lin B, Luo C, Hsu S, Lee B, Tsai H, Chao S, Wang J, Chen T, Chen C, Chang H, Wang C. A retrospective study of pulmonary infarction in patients with systemic lupus erythematosus from southern Taiwan. Lupus 2011;20:876-85. [DOI: 10.1177/0961203311401458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
476 Gil-Etayo FJ, Garcinuño S, Lalueza A, Díaz-Simón R, García-Reyne A, Pleguezuelo DE, Cabrera-Marante O, Rodriguez-Frias EA, Perez-Rivilla A, Serrano M, Serrano A. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines 2021;9:899. [PMID: 34440103 DOI: 10.3390/biomedicines9080899] [Reference Citation Analysis]
477 Derebail VK, Rheault MN, Kerlin BA. Role of direct oral anticoagulants in patients with kidney disease. Kidney Int 2020;97:664-75. [PMID: 32107019 DOI: 10.1016/j.kint.2019.11.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
478 Khwaja J. Bilateral adrenal hemorrhage in the background of Escherichia coli sepsis: a case report. J Med Case Rep 2017;11:72. [PMID: 28302165 DOI: 10.1186/s13256-017-1236-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
479 Bertero MT, Bazzan M, Carignola R, Montaruli B, Silvestro E, Sciascia S, Vaccarino A, Baldovino S, Roccatello D; Antiphospholipid Piedmont Consortium. Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. Lupus 2012;21:806-9. [PMID: 22635240 DOI: 10.1177/0961203312446974] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
480 Van Hoecke F, Persijn L, Decavele A, Devreese K. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Int J Lab Hematol 2012;34:630-40. [DOI: 10.1111/j.1751-553x.2012.01448.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
481 Berkman SA, Song SS. Ischemic Stroke in the Young. Clin Appl Thromb Hemost 2021;27:10760296211002274. [PMID: 33870763 DOI: 10.1177/10760296211002274] [Reference Citation Analysis]
482 Napal JJ, Neila S, Pérez-Montes R, Sierra I, Ruiz S, Hernández JL. The role of coagulation disorders in patients with retinal vein occlusion. QJM 2016;109:97-102. [PMID: 25972353 DOI: 10.1093/qjmed/hcv088] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
483 Clark CA, Spitzer KA, Laskin CA. Obstetric Antiphospholipid Syndrome: Has the Black Swan Swallowed a Red Herring? J Rheumatol 2015;42:155-7. [DOI: 10.3899/jrheum.140760] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
484 Ripoll VM, Pregnolato F, Mazza S, Bodio C, Grossi C, McDonnell T, Pericleous C, Meroni PL, Isenberg DA, Rahman A, Giles IP. Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome. J Autoimmun 2018;93:114-23. [PMID: 30033000 DOI: 10.1016/j.jaut.2018.07.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
485 Ames PR, Matsuura E, Batuca JR, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Alves JD. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome. Lupus. 2010;19:711-716. [PMID: 20064910 DOI: 10.1177/0961203309357765] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
486 Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2013;27:435-47. [PMID: 24238698 DOI: 10.1016/j.berh.2013.07.005] [Cited by in Crossref: 89] [Cited by in F6Publishing: 66] [Article Influence: 11.1] [Reference Citation Analysis]
487 Krilis SA, Giannakopoulos B. Laboratory methods to detect antiphospholipid antibodies. Hematology Am Soc Hematol Educ Program 2014;2014:321-8. [PMID: 25696873 DOI: 10.1182/asheducation-2014.1.321] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
488 Ferrari E, Sartre B, Squara F, Contenti J, Occelli C, Lemoel F, Levraut J, Doyen D, Dellamonica J, Mondain V, Chirio D, Risso K, Cua E, Orban JC, Ichai C, Labbaoui M, Mossaz B, Moceri P, Appert-Flory A, Fischer F, Toulon P. High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019. J Am Heart Assoc 2020;9:e017773. [PMID: 32972320 DOI: 10.1161/JAHA.120.017773] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
489 Capozzi A, Riitano G, Recalchi S, Manganelli V, Costi R, Saccoliti F, Pulcinelli F, Garofalo T, Misasi R, Longo A, Di Santo R, Sorice M. Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies. J Thromb Haemost 2021;19:2302-13. [PMID: 34107171 DOI: 10.1111/jth.15417] [Reference Citation Analysis]
490 Ducloy-bouthors A. Hémostase et prééclampsie. Annales Françaises d'Anesthésie et de Réanimation 2010;29:e121-34. [DOI: 10.1016/j.annfar.2010.03.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
491 Erkan D, Vega J, Ramón G, Kozora E, Lockshin MD. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis & Rheumatism 2013;65:464-71. [DOI: 10.1002/art.37759] [Cited by in Crossref: 179] [Cited by in F6Publishing: 131] [Article Influence: 19.9] [Reference Citation Analysis]
492 Mejía-vilet JM, Córdova-sánchez BM, Uribe-uribe NO, Correa-rotter R, Morales-buenrostro LE. Prognostic significance of renal vascular pathology in lupus nephritis. Lupus 2017;26:1042-50. [DOI: 10.1177/0961203317692419] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
493 Amin H, Greer DM. Cryptogenic Stroke—The Appropriate Diagnostic Evaluation. Curr Treat Options Cardio Med 2014;16. [DOI: 10.1007/s11936-013-0280-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
494 Veskitkul J, Ruangchira-urai R, Charuvanij S, Pongtanakul B, Udomittipong K, Vichyanond P. Asthma-like symptoms as a presentation of antiphospholipid syndrome. Pediatr Pulmonol 2015;50:E1-4. [PMID: 25045120 DOI: 10.1002/ppul.23079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
495 Bertolaccini ML, Khamashta MA. Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 2006;15:172-8. [DOI: 10.1191/0961203306lu2293rr] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
496 Patsouras MD, Sikara MP, Grika EP, Moutsopoulos HM, Tzioufas AG, Vlachoyiannopoulos PG. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome. J Autoimmun 2015;65:30-7. [PMID: 26283469 DOI: 10.1016/j.jaut.2015.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
497 Plasín-Rodríguez MA, Patricio P, Monteagudo J, García-Criado A, Cervera R, Reverter JC, Espinosa G, Tàssies D. Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus. J Thromb Thrombolysis 2021;52:30-41. [PMID: 33011897 DOI: 10.1007/s11239-020-02295-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
498 Arache W, Bahadi A, Kabbaj DE. [Renal artery thrombosis revealing antiphospholipid antibody syndrome]. Pan Afr Med J 2018;31:150. [PMID: 31037210 DOI: 10.11604/pamj.2018.31.150.15677] [Reference Citation Analysis]
499 Fonseca MES, Balbi GGM, Signorelli F, Gouvea CP, de Andrade DCO. CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome. Lupus 2022;:9612033221086134. [PMID: 35266798 DOI: 10.1177/09612033221086134] [Reference Citation Analysis]
500 Tkachenko O, Lapin S, Mazing A, Emanuel V, Belolipetskaia E, Beliaeva I, Myachikova V, Maslyanskiy A, Gilburd B, Schierack P, Roggenbuck D. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis. Lupus 2020;29:490-8. [DOI: 10.1177/0961203320909952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
501 Favaloro EJ, Wong RC. Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines. Pathology 2014;46:481-95. [DOI: 10.1097/pat.0000000000000142] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 5.1] [Reference Citation Analysis]
502 Pablo RD, Cacho PM, López-Hoyos M, Calvo-Río V, Riancho-Zarrabeitia L, Martínez-Taboada VM. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study. Clin Rev Allergy Immunol 2021. [PMID: 34216367 DOI: 10.1007/s12016-021-08862-5] [Reference Citation Analysis]
503 Meroni PL. Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for? J Autoimmun 2016;75:1-5. [PMID: 27496152 DOI: 10.1016/j.jaut.2016.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
504 Waisayarat J, Plumworasawat S, Vilaiyuk S, Sirachainan N. Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature. Vasc Health Risk Manag 2019;15:253-8. [PMID: 31496715 DOI: 10.2147/VHRM.S197638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
505 Pengo V, Ruiz-irastorza G, Denas G, Andreoli L, Khamashta M, Tincani A. High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: ‘PROS’ and ‘CONS’. Autoimmunity Reviews 2012;11:577-80. [DOI: 10.1016/j.autrev.2011.10.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
506 Kwon HM, Jung KW, Moon YJ, Jung HW, Park YS, Jun IG, Song JG, Hwang GS. Prevalence of Antiphospholipid Antibody Positivity and Association of Pretransplant Lupus Anticoagulant Positivity With Early Allograft Dysfunction in Liver Transplantation. Transplant Proc 2018;50:1136-41. [PMID: 29731081 DOI: 10.1016/j.transproceed.2018.02.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
507 Budd R, Harley E, Quarshie A, Henderson V, Harris EN, Pierangeli SS. A re-appraisal of the normal cut-off assignment for anticardiolipin IgM tests. J Thromb Haemost 2006;4:2210-4. [DOI: 10.1111/j.1538-7836.2006.02134.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
508 Wong R, Favaloro E, Adelstein S, Baumgart K, Bird R, Brighton T, Empson M, Gillis D, Hendle M, Laurent R, Mallon D, Pollock W, Smith S, Steele R, Wilson R. Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology 2008;40:58-63. [DOI: 10.1080/00313020701717720] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
509 Alijotas-Reig J, Palacio-García C. [Endothelial dysfunction and circulating microparticles in patients with antiphospholipid antibodies]. Med Clin (Barc) 2012;138:134-5. [PMID: 21940006 DOI: 10.1016/j.medcli.2011.05.020] [Reference Citation Analysis]
510 Dai Y, Lin L, Lin N, He D, Guo D, Xue H, Li Y, Xie X, Xu L, He S. APA scoring system: a novel predictive model based on risk factors of pregnancy loss for recurrent spontaneous abortion patients. Journal of Obstetrics and Gynaecology. [DOI: 10.1080/01443615.2021.2021507] [Reference Citation Analysis]
511 Million M, Thuny F, Bardin N, Angelakis E, Edouard S, Bessis S, Guimard T, Weitten T, Martin-Barbaz F, Texereau M, Ayouz K, Protopopescu C, Carrieri P, Habib G, Raoult D. Antiphospholipid Antibody Syndrome With Valvular Vegetations in Acute Q Fever. Clin Infect Dis 2016;62:537-44. [PMID: 26585519 DOI: 10.1093/cid/civ956] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
512 Jaskowski TD, Wilson AR, Hill HR, Branch WD, Tebo AE. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine–prothrombin complex: Identical or distinct diagnostic tools for antiphospholipid syndrome? Clinica Chimica Acta 2009;410:19-24. [DOI: 10.1016/j.cca.2009.09.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
513 Martínez-zamora MÁ, Cervera R, Balasch J. Recurrent Miscarriage, Antiphospholipid Antibodies and the Risk of Thromboembolic Disease. Clinic Rev Allerg Immunol 2012;43:265-74. [DOI: 10.1007/s12016-012-8316-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
514 Steriade C, Titulaer MJ, Vezzani A, Sander JW, Thijs RD. The association between systemic autoimmune disorders and epilepsy and its clinical implications. Brain 2021;144:372-90. [PMID: 33221878 DOI: 10.1093/brain/awaa362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
515 Yildiz B, Cetin N, Kural N, Kaya T, Akcar N. Co-existence of renovascular hypertension, polyarteritis nodosa, antiphospholipid syndrome and methylenetetrahydrofolate reductase mutation: Polyarteritis nodosa, aPL, MTHFR. Pediatr Int 2013;55:e107-10. [DOI: 10.1111/ped.12135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
516 Whitaker KL. Antiphospholipid antibody syndrome: The difficulties of diagnosis. JAAPA 2017;30:10-4. [PMID: 29120877 DOI: 10.1097/01.JAA.0000526771.67820.59] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
517 Pontara E, Cheng C, Cattini MG, Bison E, Pelloso M, Denas G, Pengo V. An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS). Lupus 2019;28:1663-8. [PMID: 31701800 DOI: 10.1177/0961203319886915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
518 Alessandri C, Agmon-Levin N, Conti F, Perricone C, Ortona E, Pendolino M, Capozzi A, Delunardo F, Mancini R, Truglia S, Spinelli FR, Ceccarelli F, Sorice M, Shoenfeld Y, Valesini G. Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features. Immunol Res 2017;65:524-31. [PMID: 28215033 DOI: 10.1007/s12026-017-8899-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
519 Cikrikcioglu MA, Hursitoglu M, Erkal H, Inan B, Ozturk T, Cakirca M, Canpolat F, Erkal S, Bahtiyar I, Cordan I, Tukek T. Splenomegaly in primary antiphospholipid syndrome without accompanying portal hypertension or comorbidity. Pathophysiol Haemost Thromb 2010;37:104-9. [PMID: 21555872 DOI: 10.1159/000327506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
520 Mayer-Pickel K, Stern C, Eberhard K, Lang U, Obermayer-Pietsch B, Cervar-Zivkovic M. Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus. J Reprod Immunol 2018;127:19-23. [PMID: 29689494 DOI: 10.1016/j.jri.2018.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
521 Devreese KM. A functional coagulation test to identify anti-β2-glycoprotein I dependent lupus anticoagulants. Thrombosis Research 2007;119:753-9. [DOI: 10.1016/j.thromres.2006.06.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
522 Henriques CC, Lourenço F, Lopéz B, Panarra A, Riso N. Antiphospholipid syndrome and recurrent thrombosis--limitations of current treatment strategies. BMJ Case Rep 2012;2012:bcr1120115147. [PMID: 22605591 DOI: 10.1136/bcr.11.2011.5147] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
523 Pyrpasopoulou A, Triantafyllou A, Anyfanti P, Douma S, Aslanidis S. Capillaroscopy as a screening test for clinical antiphospholipid syndrome. Eur J Intern Med 2011;22:e158-9. [PMID: 22075311 DOI: 10.1016/j.ejim.2011.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
524 Ortel TL, Erkan D, Lockshin MD. Antiphospholipid Syndrome. Clinical Immunology. Elsevier; 2019. pp. 835-841.e1. [DOI: 10.1016/b978-0-7020-6896-6.00061-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
525 Debouverie O, Roblot P, Roy-péaud F, Boinot C, Pierre F, Pourrat O. Évolution d’une thrombopénie chronique idiopathique en cours de grossesse (62 grossesses). La Revue de Médecine Interne 2012;33:426-32. [DOI: 10.1016/j.revmed.2012.04.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
526 Zhou H, Yan Y, Xu G, Zhou B, Wen H, Guo D, Zhou F, Wang H. Toll-like receptor (TLR)-4 mediates anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells. Clin Exp Immunol 2011;163:189-98. [PMID: 21091668 DOI: 10.1111/j.1365-2249.2010.04291.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
527 Bećarević M, Čabarkapa V, Đerić M, Ignjatović S. Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary Data. Clin Appl Thromb Hemost 2017;23:379-83. [PMID: 27056935 DOI: 10.1177/1076029616642512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
528 Freeman H, Patel J, Fernandez D, Sharples P, Ramanan AV. Fitting and flailing: recognition of paediatric antiphospholipid syndrome. Arch Dis Child Educ Pract Ed 2014;99:28-36. [PMID: 24091699 DOI: 10.1136/archdischild-2012-302404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
529 Freire de Carvalho J, Correia de Araujo RP, Skare TL. Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia. Rheumatol Ther 2021;8:1255-61. [PMID: 34228316 DOI: 10.1007/s40744-021-00333-9] [Reference Citation Analysis]
530 Yelnik CM, Urbanski G, Drumez E, Sobanski V, Maillard H, Lanteri A, Morell-Dubois S, Caron C, Dubucquoi S, Launay D, Duhamel A, Hachulla E, Hatron PY, Lambert M. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity. Lupus. 2017;26:163-169. [PMID: 27432808 DOI: 10.1177/0961203316657433] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
531 Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OGP, Silva GS, de Souza AWS, Andrade D. Neurologic manifestations of antiphospholipid syndrome. Lupus 2018;27:1404-14. [DOI: 10.1177/0961203318776110] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
532 Amengual O, Forastiero R, Sugiura-Ogasawara M, Otomo K, Oku K, Favas C, Delgado Alves J, Žigon P, Ambrožič A, Tomšič M, Ruiz-Arruza I, Ruiz-Irastorza G, Bertolaccini ML, Norman GL, Shums Z, Arai J, Murashima A, Tebo AE, Gerosa M, Meroni PL, Rodriguez-Pintó I, Cervera R, Swadzba J, Musial J, Atsumi T. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study. Lupus 2017;26:266-76. [PMID: 27510605 DOI: 10.1177/0961203316660203] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
533 Ye Y, Hu Z, Liu J, Chen G, Zhou Y, Yu L. Detection of anticardiolipin antibody IgG by time-resolved fluoroimmunoassay. Clin Rheumatol 2012;31:1339-45. [PMID: 22684164 DOI: 10.1007/s10067-012-2020-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
534 Lin CY, Broström A, Nilsen P, Pakpour AH. Using extended theory of planned behavior to understand aspirin adherence in pregnant women. Pregnancy Hypertens 2018;12:84-9. [PMID: 29674206 DOI: 10.1016/j.preghy.2018.04.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
535 Bertolaccini M, Murru V, Sciascia S, Sanna G, Khamashta M. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE). Thrombosis Research 2012;130:914-8. [DOI: 10.1016/j.thromres.2012.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
536 Tufano A, Lembo M, Di Minno MN, Nardo A, Esposito R, Santoro C, Buonauro A, Cerbone AM, Di Minno G, Galderisi M. Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study. Int J Cardiol 2018;271:366-70. [PMID: 30223375 DOI: 10.1016/j.ijcard.2018.05.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
537 Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, Petri M, Porter TF, Sammaritano L, Stephenson MD, Buyon J, Salmon JE. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012;64:2311-8. [PMID: 22275304 DOI: 10.1002/art.34402] [Cited by in Crossref: 228] [Cited by in F6Publishing: 181] [Article Influence: 22.8] [Reference Citation Analysis]
538 Azuma H, Yamamoto T, Chishima F. Effects of anti-β2-GPI antibodies on cytokine production in normal first-trimester trophoblast cells. J Obstet Gynaecol Res 2016;42:769-75. [PMID: 27098191 DOI: 10.1111/jog.12993] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
539 de Moerloose P, Fickentscher C, Boehlen F, Tiercy JM, Kruithof EKO, Brandt KJ. Patient-derived anti-β2GP1 antibodies recognize a peptide motif pattern and not a specific sequence of residues. Haematologica 2017;102:1324-32. [PMID: 28550190 DOI: 10.3324/haematol.2017.170381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
540 Sahin M, Oguz A, Tuzun D, Boysan SN, Mese B, Sahin H, Gul K. Primary Adrenal Failure due to Antiphospholipid Syndrome. Case Rep Endocrinol 2015;2015:161497. [PMID: 26583075 DOI: 10.1155/2015/161497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
541 Zahid H, Hassan S, Gul S, Rizwan K, Khan SU, Maghazi MA. Co-existing Bilateral Pulmonary Embolism and Intra-cardiac Mass: A Case of Catastrophic Antiphospholipid Syndrome-like Disease. Cureus 2018;10:e3438. [PMID: 30546985 DOI: 10.7759/cureus.3438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
542 Normand G, Sens F, Puthet J, Jourde-Chiche N, Lemoine S, Chauveau D, Moranne O, Rémy P, Doret M, Daugas E, Juillard L; French Collaborative Group on Lupus Nephritis. Not only disease activity but also chronic hypertension and overweight are determinants of pregnancy outcomes in patients with systemic lupus erythematosus. Lupus 2019;28:529-37. [PMID: 30799679 DOI: 10.1177/0961203319832097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
543 McNamee KM, Dawood F, Farquharson RG. Mid-trimester pregnancy loss. Obstet Gynecol Clin North Am 2014;41:87-102. [PMID: 24491985 DOI: 10.1016/j.ogc.2013.10.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
544 Erkan D, Pierangeli SS. Could statins be a new therapeutic option for antiphospholipid syndrome patients? Expert Review of Hematology 2014;6:115-7. [DOI: 10.1586/ehm.13.8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
545 Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Nephrology 2007;12:474-80. [DOI: 10.1111/j.1440-1797.2007.00792.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
546 Cohen H, Mackie IJ, Devreese KMJ; International Society for Thrombosis and Haemostasis Scientific and Standardization Committee for Lupus Anticoagulant/Antiphospholipid Antibodies. Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey. J Thromb Haemost 2019;17:1715-32. [PMID: 31271706 DOI: 10.1111/jth.14560] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
547 Andreoli L, Tincani A. Beyond the "syndrome": antiphospholipid antibodies as risk factors. Arthritis Rheum 2012;64:342-5. [PMID: 21953446 DOI: 10.1002/art.33341] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
548 Beato Merino MJ, Diago A, Fernandez-Flores A, Fraga J, García Herrera A, Garrido M, Idoate Gastearena MA, Llamas-Velasco M, Monteagudo C, Onrubia J, Pérez-González YC, Pérez Muñoz N, Ríos-Martín JJ, Ríos-Viñuela E, Rodríguez Peralto JL, Rozas Muñoz E, Sanmartín O, Santonja C, Santos-Briz A, Saus C, Suárez Peñaranda JM, Velasco Benito V. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occusion - Part II: Coagulation Disorders, Emboli, and Other. Actas Dermosifiliogr (Engl Ed) 2021;112:103-17. [PMID: 33075291 DOI: 10.1016/j.ad.2020.10.004] [Reference Citation Analysis]
549 Ahluwalia J, Sreedharanunni S. The Laboratory Diagnosis of the Antiphospholipid Syndrome. Indian J Hematol Blood Transfus 2017;33:8-14. [PMID: 28194050 DOI: 10.1007/s12288-016-0739-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
550 Lockshin MD. Pregnancy and antiphospholipid syndrome. Am J Reprod Immunol 2013;69:585-7. [PMID: 23279134 DOI: 10.1111/aji.12071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
551 Mayer M, Cerovec M, Rados M, Cikes N. Antiphospholipid syndrome and central nervous system. Clin Neurol Neurosurg 2010;112:602-8. [PMID: 20417026 DOI: 10.1016/j.clineuro.2010.03.023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
552 Montaruli B, De Luna E, Mengozzi G, Molinari F, Napolitano E, Napoli P, Nicolo C, Romito A, Stella S, Bazzan M, Bertero M, Carignola R, Marchese C. Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy. Lupus 2012;21:799-801. [DOI: 10.1177/0961203312442260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
553 Sanmarco M, Bardin N, Camoin L, Beziane A, Dignat-George F, Gamerre M, Porcu G. Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization. Ann N Y Acad Sci 2007;1108:457-65. [PMID: 17894010 DOI: 10.1196/annals.1422.048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
554 Sussman B, Simmons BB. Antiphospholipid antibody syndrome causing acute myocardial infarction in a young adult. Osteopathic Family Physician 2010;2:139-43. [DOI: 10.1016/j.osfp.2010.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
555 Neki R, Mitsuguro M, Okamoto A, Ida K, Miyoshi T, Kamiya C, Iwanaga N, Miyata T, Yoshimatsu J. A less-intensive anticoagulation protocol of therapeutic unfractionated heparin administration for pregnant patients. Int J Hematol 2019;110:550-8. [DOI: 10.1007/s12185-019-02712-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
556 Brusch A. The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome. Antibodies (Basel) 2016;5:E16. [PMID: 31557997 DOI: 10.3390/antib5020016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
557 Noordermeer T, Molhoek JE, Schutgens REG, Sebastian SAE, Drost-Verhoef S, van Wesel ACW, de Groot PG, Meijers JCM, Urbanus RT. Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action. J Thromb Haemost 2021;19:1018-28. [PMID: 33421291 DOI: 10.1111/jth.15241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
558 Yu X, He L. Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: A systematic review and meta-analysis. Exp Ther Med 2021;21:57. [PMID: 33365057 DOI: 10.3892/etm.2020.9489] [Reference Citation Analysis]
559 Moore GW, Maloney JC, de Jager N, Dunsmore CL, Gorman DK, Polgrean RF, Bertolaccini ML. Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples. Res Pract Thromb Haemost 2017;1:62-8. [PMID: 30046675 DOI: 10.1002/rth2.12006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
560 Li CZ, Liu FC, Li CC, Lin MC, Hsieh CC, Lin BJ, Chen NF, Chen CL, Chung TT, Tang CT, Hueng DY, Ju DT, Ma HI, Liu MY, Lu CH, Chen YH. The Efficacy of Therapeutic Plasma Exchange in Antiphospholipid Antibody-positive Patients With Spontaneous Intracerebral Hemorrhage and High D-dimer Levels. Neurologist 2018;23:7-11. [PMID: 29266037 DOI: 10.1097/NRL.0000000000000159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
561 Erez D, Abarbuch E, Natour A, Meyer A, Natour A, Dovrish Z, Levy Y. Audiological disturbances in patients with primary antiphospholipid syndrome. Lupus 2020;29:533-8. [DOI: 10.1177/0961203320904780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
562 Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna) 2013;120:1579-89. [PMID: 23580159 DOI: 10.1007/s00702-013-1023-z] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
563 Murtaza G, Iskandar J, Humphrey T, Adhikari S, Kuruvilla A. Lupus-Negative Libman-Sacks Endocarditis Complicated by Catastrophic Antiphospholipid Syndrome. Cardiol Res 2017;8:57-62. [PMID: 28515823 DOI: 10.14740/cr534e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
564 Furmańczyk-zawiska A, Tronina O, Ba̧czkowska T, Chmura A, Durlik M. The Significance of Antiphospholipid Antibodies in Liver Recipients. Transplantation Proceedings 2013;45:1983-9. [DOI: 10.1016/j.transproceed.2013.01.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
565 Heit JA, Beckman MG, Bockenstedt PL, Grant AM, Key NS, Kulkarni R, Manco-Johnson MJ, Moll S, Ortel TL, Philipp CS; CDC Thrombosis and Hemostasis Centers Research and Prevention Network. Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol 2010;85:467-71. [PMID: 20575037 DOI: 10.1002/ajh.21735] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
566 Drijkoningen J, Damoiseaux J, van Paassen P, Tervaert JW. Clinical manifestations of the anti-phospholipid syndrome as defined by the updated Sapporo classification criteria. Ann Rheum Dis 2007;66:1407-8. [PMID: 17881670 DOI: 10.1136/ard.2007.070680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
567 Bernal-Macías S, Reyes-Beltrán B, Molano-González N, Augusto Vega D, Bichernall C, Díaz LA, Rojas-Villarraga A, Anaya JM. Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis. Lupus Sci Med 2015;2:e000122. [PMID: 26688741 DOI: 10.1136/lupus-2015-000122] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
568 Tavakoli M, Roghaee S, Soheilian R, Soheilian M. Antiphospholipid syndrome following toxoplasma retinochoroiditis. Ocul Immunol Inflamm 2011;19:311-3. [PMID: 21864013 DOI: 10.3109/09273948.2011.596302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
569 Soybilgic A, Avcin T. Pediatric APS: State of the Art. Curr Rheumatol Rep 2020;22:9. [PMID: 32124078 DOI: 10.1007/s11926-020-0887-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
570 Poulton K, Rahman A, Giles I. Examining How Antiphospholipid Antibodies Activate Intracellular Signaling Pathways: A Systematic Review. Seminars in Arthritis and Rheumatism 2012;41:720-36. [DOI: 10.1016/j.semarthrit.2011.09.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
571 Chiganer EH, Hryb JP, Carnero Contentti E. Mielitis y lupus: clínica, diagnóstico y tratamiento. Revisión. Reumatología Clínica 2017;13:344-8. [DOI: 10.1016/j.reuma.2016.06.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
572 Tanimura K, Saito S, Nakatsuka M, Nagamatsu T, Fujii T, Fukui A, Deguchi M, Sasagawa Y, Arase N, Arase H, Yamada H. The β 2 -Glycoprotein I/HLA-DR Complex As a Major Autoantibody Target in Obstetric Antiphospholipid Syndrome. Arthritis Rheumatol 2020;72:1882-91. [PMID: 32583563 DOI: 10.1002/art.41410] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
573 Castillo-martínez D, Rivera V, Mouneu-ornelas N, Martínez-martínez LA, Jiménez-rojas V, Márquez-velasco R, Amezcua-guerra L. Levels of anti-Müllerian hormone in premenopausal women with the antiphospholipid syndrome and its association with the risk of clinical complications. Lupus 2019;28:427-31. [DOI: 10.1177/0961203319828507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
574 Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
575 Benhamou Y, Miranda S, Armengol G, Harouki N, Drouot L, Zahr N, Thuillez C, Boyer O, Levesque H, Joannides R, Richard V. Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress. Vascular Pharmacology 2015;71:93-101. [DOI: 10.1016/j.vph.2015.03.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
576 Vivero F, Gonzalez-Echavarri C, Ruiz-Estevez B, Maderuelo I, Ruiz-Irastorza G. Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus. Autoimmun Rev 2016;15:1134-40. [PMID: 27639157 DOI: 10.1016/j.autrev.2016.09.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
577 Romay-Penabad Z, Carrera Marin AL, Willis R, Weston-Davies W, Machin S, Cohen H, Brasier A, Gonzalez EB. Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies. Lupus 2014;23:1324-6. [PMID: 25228739 DOI: 10.1177/0961203314546022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
578 Comarmond C, Jego P, Veyssier-belot C, Marie I, Mekinian A, Elmaleh-sachs A, Leroux G, Saadoun D, Oziol E, Fraisse T, Hyvernat H, Thiercein-legrand M, Sarrot-reynauld F, Ferreira-maldent N, de Menthon M, Goujard C, Khau D, Nguen Y, Monnier S, Michon A, Castel B, Decaux O, Piette J, Cacoub P. Cessation of oral anticoagulants in antiphospholipid syndrome. Lupus 2017;26:1291-6. [DOI: 10.1177/0961203317699285] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
579 Zemet R, Dulitzki M, Baum M, Ofer Friedman H, Morag I, Simchen MJ. Early-onset preeclampsia - The impact of antiphospholipid antibodies on disease severity. Eur J Obstet Gynecol Reprod Biol 2021;263:79-84. [PMID: 34167038 DOI: 10.1016/j.ejogrb.2021.06.006] [Reference Citation Analysis]
580 Sarecka-Hujar B, Kopyta I. Antiphospholipid syndrome and its role in pediatric cerebrovascular diseases: A literature review. World J Clin Cases 2020; 8(10): 1806-1817 [PMID: 32518771 DOI: 10.12998/wjcc.v8.i10.1806] [Reference Citation Analysis]
581 Plazak W, Pasowicz M, Kostkiewicz M, Podolec J, Tomkiewicz-Pajak L, Musial J, Podolec P. Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients. Inflamm Res 2011;60:973-80. [PMID: 21744266 DOI: 10.1007/s00011-011-0358-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
582 Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol 2020;146:32-40. [PMID: 32681845 DOI: 10.1016/j.yjmcc.2020.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
583 Mobarrez F, Vikerfors A, Gustafsson JT, Gunnarsson I, Zickert A, Larsson A, Pisetsky DS, Wallén H, Svenungsson E. Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations. Sci Rep 2016;6:36025. [PMID: 27777414 DOI: 10.1038/srep36025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 7.5] [Reference Citation Analysis]
584 Živković I, Petrušić V, Stojanović M, Inić-kanada A, Stojićević I, Dimitrijević L. Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied adjuvant. Innate Immun 2012;18:333-42. [DOI: 10.1177/1753425911407361] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
585 Basaran A, Deren Ö, Buyukasik Y, Basaran M. Free protein s reference ranges in gravidas without hereditary and acquired thrombophilia. Indian J Hematol Blood Transfus 2015;31:286-91. [PMID: 25825574 DOI: 10.1007/s12288-014-0448-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
586 Voigtlaender M, Langer F. Management of Vascular Thrombosis in Patients with Thrombocytopenia. Hamostaseologie 2021. [PMID: 34933376 DOI: 10.1055/a-1675-7824] [Reference Citation Analysis]
587 Blank M, Krause I, Dotan N, Anafi L, Eisenstein M, Cervera R, Meroni P, Shoenfeld Y. Anti-GalNAcβ: A novel anti-glycan autoantibody associated with pregnancy loss in women with antiphospholipid syndrome and in a mouse experimental model. Journal of Autoimmunity 2012;39:420-7. [DOI: 10.1016/j.jaut.2012.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
588 Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun 2020;3:100073. [PMID: 33263103 DOI: 10.1016/j.jtauto.2020.100073] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
589 Mannucci PM, Franchini M. The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolism. Expert Review of Hematology 2014;7:757-65. [DOI: 10.1586/17474086.2014.960385] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
590 Turrent-Carriles A, Herrera-Félix JP, Amigo MC. Renal Involvement in Antiphospholipid Syndrome. Front Immunol 2018;9:1008. [PMID: 29867982 DOI: 10.3389/fimmu.2018.01008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
591 Sciascia S, Radin M. Thrombotic antiphospholipid syndrome. Lupus 2018;27:21-7. [PMID: 30452325 DOI: 10.1177/0961203318801686] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
592 Janko C, André S, Munoz L, Briand J, Schorn C, Winkler S, Schiller M, Andreoli L, Manfredi A, Isenberg D, Schett G, Gabius H, Muller S, Herrmann M. Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome. Lupus 2012;21:781-3. [DOI: 10.1177/0961203312443422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
593 Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 2011;50:1684-9. [PMID: 21652586 DOI: 10.1093/rheumatology/ker139] [Cited by in Crossref: 142] [Cited by in F6Publishing: 121] [Article Influence: 12.9] [Reference Citation Analysis]
594 Abou-nassar K, Carrier M, Ramsay T, Rodger MA. The association between antiphospholipid antibodies and placenta mediated complications: A systematic review and meta-analysis. Thrombosis Research 2011;128:77-85. [DOI: 10.1016/j.thromres.2011.02.006] [Cited by in Crossref: 106] [Cited by in F6Publishing: 78] [Article Influence: 9.6] [Reference Citation Analysis]
595 Willemze R, Bradford RL, Mooberry MJ, Roubey RA, Key NS. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications. Thromb Res. 2014;133:187-189. [PMID: 24332063 DOI: 10.1016/j.thromres.2013.11.027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
596 Gomes V, Mesquita A, Capela C. Autoimmune diseases and pregnancy: analysis of a series of cases. BMC Res Notes 2015;8:216. [PMID: 26040452 DOI: 10.1186/s13104-015-1177-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
597 Matsuki Y, Atsumi T, Yamaguchi K, Hisano M, Arata N, Oku K, Watanabe N, Sago H, Takasaki Y, Murashima A. Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complications. Modern Rheumatology 2014;25:215-8. [DOI: 10.3109/14397595.2014.942503] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
598 Gerde M, Ibarra E, Mac Kenzie R, Fernandez Suarez C, Heer C, Alvarez R, Iglesias M, Balparda J, Beruti E, Rubinstein F. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thromb Res 2021;206:104-10. [PMID: 34454240 DOI: 10.1016/j.thromres.2021.08.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
599 Cruz ACL, Colella MP, De Paula EV, Annichinno-bizzachi J, Orsi FA. Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies. European Journal of Internal Medicine 2019;69:e6-7. [DOI: 10.1016/j.ejim.2019.08.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
600 Andreeva H, Seip M, Koycheva S. Live Birth Pregnancy Outcome after First In Vitro Fertilization Treatment in a Patient with Systemic Lupus Erythematosus and Isolated High Positive IgA Anti-β2glycoprotein I Antibodies: A Case Report. Open Med (Wars) 2017;12:12-8. [PMID: 28401195 DOI: 10.1515/med-2017-0003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
601 Yin D, de Laat B, Devreese KMJ, Kelchtermans H. The clinical value of assays detecting antibodies against domain I of β2-glycoprotein I in the antiphospholipid syndrome. Autoimmun Rev 2018;17:1210-8. [PMID: 30316989 DOI: 10.1016/j.autrev.2018.06.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
602 Lu Y, Dong Y, Zhang Y, Shen D, Wang X, Ge R, Zhang M, Xia Y, Wang X. Antiphospholipid antibody-activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome. J Cell Mol Med 2020;24:6690-703. [PMID: 32369873 DOI: 10.1111/jcmm.15321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
603 Karadağ C, Yoldemir T, Karadağ SD, İnan C, Dolgun ZN, Aslanova L. Obstetric outcomes of recurrent pregnancy loss patients diagnosed wıth inherited thrombophilia. Ir J Med Sci 2017;186:707-13. [DOI: 10.1007/s11845-017-1569-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
604 Dufrost V, Risse J, Zuily S, Wahl D. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature. Curr Rheumatol Rep 2016;18. [DOI: 10.1007/s11926-016-0623-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
605 Wiseman SJ, Bastin ME, Amft EN, Belch JFF, Ralston SH, Wardlaw JM. Cognitive function, disease burden and the structural connectome in systemic lupus erythematosus. Lupus 2018;27:1329-37. [PMID: 29722629 DOI: 10.1177/0961203318772666] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
606 Duffett L, Rodger M. LMWH to prevent placenta-mediated pregnancy complications: an update. Br J Haematol 2015;168:619-38. [DOI: 10.1111/bjh.13209] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
607 Kraft C, Schuettfort G, Weil Y, Tirneci V, Kasper A, Haberichter B, Schwonberg J, Schindewolf M, Lindhoff-Last E, Linnemann B. Thrombosis of the inferior vena cava and malignant disease. Thromb Res 2014;134:668-73. [PMID: 25081831 DOI: 10.1016/j.thromres.2014.07.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
608 Dolin HH, Dziuba M, Pappada SM, Papadimos TJ. Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association. Clin Case Rep 2019;7:1984-8. [PMID: 31624623 DOI: 10.1002/ccr3.2416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
609 Losonczy LI, Johnson B, Sidhu J, Li J, Feeney CM. Seronegative catastrophic antiphospholipid syndrome in a young female presenting with a headache. J Emerg Med 2015;48:294-7. [PMID: 25559391 DOI: 10.1016/j.jemermed.2014.06.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
610 Andreoli L, Tincani A. 25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. Intern Emerg Med 2009;4:165-7. [DOI: 10.1007/s11739-008-0222-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
611 Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thrombosis Research 2009;123:482-7. [DOI: 10.1016/j.thromres.2008.03.012] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 5.7] [Reference Citation Analysis]
612 Härle P. [Rheumatological emergency on the edge of intensive care medicine]. Z Rheumatol 2019;78:915-24. [PMID: 31605194 DOI: 10.1007/s00393-019-00696-z] [Reference Citation Analysis]
613 Yelnik C, Puigrenier S, Lambert M. Négativation des anticorps antiphospholipides et arrêt du traitement anticoagulant au cours du syndrome des antiphospholipides : qu’en penser ? La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.04.033] [Reference Citation Analysis]
614 Szodoray P, Hajas A, Toth L, Szakall S, Nakken B, Soltesz P, Bodolay E. The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome. Lupus 2014;23:1079-84. [DOI: 10.1177/0961203314533602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
615 Kolyada A, Barrios DA, Beglova N. Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops. Antibodies (Basel) 2017;6:8. [PMID: 28748111 DOI: 10.3390/antib6020008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
616 Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, Su Y, Li ZG. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. Clin Rheumatol 2017;36:401-6. [PMID: 28050648 DOI: 10.1007/s10067-016-3498-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
617 Avcin T, Cimaz R, Rozman B; Ped-APS Registry Collaborative Group. The Ped-APS Registry: the antiphospholipid syndrome in childhood. Lupus 2009;18:894-9. [PMID: 19671789 DOI: 10.1177/0961203309106917] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
618 Hornsby LB, Armstrong EM, Bellone JM, Treadway S, Phillippe HM. Thrombophilia Screening. J Pharm Pract 2014;27:253-9. [PMID: 24739279 DOI: 10.1177/0897190014530426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
619 Pisoni CN, Cuadrado MJ, Khamashta MA, Hunt BJ. Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil). Lupus 2006;15:877-80. [DOI: 10.1177/0961203306071706] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
620 Wu Y, V. Nguyen A, Wu X, Loh M, Vu M, Zou Y, Liu Q, Guo P, Wang Y, Montgomery LL, Orlofsky A, Rand JH, Lin EY. Antiphospholipid Antibodies Promote Tissue Factor–Dependent Angiogenic Switch and Tumor Progression. The American Journal of Pathology 2014;184:3359-75. [DOI: 10.1016/j.ajpath.2014.07.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
621 de Mesquita HL, de Carvalho GR, Aarestrup FM, do Amaral Corrêa JO, Andrade Azevedo MR. Avaliação da agregação plaquetária em presença de anticorpos antifosfolípides: anti-β2GP1 e anticardiolipina. Revista Brasileira de Reumatologia 2013;53:400-4. [DOI: 10.1590/s0482-50042013000500006] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
622 Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-chalumeau N, Cuadrado MJ, Dörner T, Ferrer-oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 2019;78:1296-304. [DOI: 10.1136/annrheumdis-2019-215213] [Cited by in Crossref: 233] [Cited by in F6Publishing: 187] [Article Influence: 77.7] [Reference Citation Analysis]
623 Jayakody Arachchillage DR, Machin SJ, Cohen H. Antithrombotic treatment for stroke associated with antiphospholipid antibodies. Expert Review of Hematology 2014;7:169-72. [DOI: 10.1586/17474086.2014.892413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
624 Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost. 2009;7:1070-1074. [PMID: 19291166 DOI: 10.1111/j.1538-7836.2009.03335.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
625 Siddique S, Risse J, Canaud G, Zuily S. Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy? Curr Rheumatol Rep 2017;19:64. [PMID: 28871481 DOI: 10.1007/s11926-017-0687-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
626 Svenungsson E, Spaak J, Strandberg K, Wallén HN, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Malmqvist K, Elvin K, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P. Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries. J Intern Med 2021. [PMID: 34820922 DOI: 10.1111/joim.13409] [Reference Citation Analysis]
627 Alijotas-Reig J, Ferrer-Oliveras R; EUROAPS Study Group. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report. Lupus 2012;21:766-8. [PMID: 22635227 DOI: 10.1177/0961203312440058] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
628 Nojima J, Motoki Y, Hara K, Sakata T, Tsuneoka H, Ichihara K. Detection of antibodies against domain 1 of β 2 -glycoprotein I is key in predicting thromboembolic complications in patients with systemic lupus erythematosus. Thrombosis Research 2017;153:83-4. [DOI: 10.1016/j.thromres.2017.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
629 Mirouse A, Parrot A, Audigier V, Demoule A, Mayaux J, Géri G, Mariotte E, Bréchot N, de Prost N, Vautier M, Neuville M, Bigé N, de Montmollin E, Cacoub P, Resche-Rigon M, Cadranel J, Saadoun D. Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study. Crit Care 2020;24:231. [PMID: 32423434 DOI: 10.1186/s13054-020-02936-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
630 Koh JH, Ko HS, Kwok S, Ju JH, Park S. Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus. Lupus 2015;24:210-7. [DOI: 10.1177/0961203314555352] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
631 Delluc A, Rousseau A, Le Galudec M, Canceil O, Woodhams B, Etienne S, Walter M, Mottier D, Van Dreden P, Lacut K. Prevalence of antiphospholipid antibodies in psychiatric patients users and non-users of antipsychotics. Br J Haematol 2014;164:272-9. [DOI: 10.1111/bjh.12627] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
632 Nalli C, Galli J, Lazzaroni MG, Andreoli L, Fazzi E, Tincani A. Long-term outcome of children born from mothers with autoimmune diseases. Best Pract Res Clin Obstet Gynaecol 2020;64:107-16. [PMID: 31787531 DOI: 10.1016/j.bpobgyn.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
633 Johnsen S, Lauvsnes MB, Omdal R. Treatment failure of direct oral anticoagulants in anti-phospholipid syndrome. Scand J Rheumatol 2018;47:427-8. [PMID: 29297243 DOI: 10.1080/03009742.2017.1369156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
634 Sacks HS, Smirnoff M, Carson D, Cooney ML, Shapiro MZ, Hahn CJ, Dasaro CR, Crowson C, Tassiulas I, Hirten RP, Cohen BL, Haber RS, Davies TF, Simpson DM, Crane MA, Harrison DJ, Luft BJ, Moline JM, Udasin IG, Todd AC, Sloan NL, Teitelbaum SL. Autoimmune conditions in the World Trade Center general responder cohort: A nested case-control and standardized incidence ratio analysis. Am J Ind Med 2022;65:117-31. [PMID: 34825393 DOI: 10.1002/ajim.23313] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
635 Tincani A, Nalli C, Khizroeva J, Bitsadze V, Lojacono A, Andreoli L, Shoenfeld Y, Makatsariya A. Autoimmune diseases and pregnancy. Best Pract Res Clin Endocrinol Metab 2019;33:101322. [PMID: 31542218 DOI: 10.1016/j.beem.2019.101322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
636 Ioannou Y, Pericleous C, Giles I, Latchman DS, Isenberg DA, Rahman A. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum. 2007;56:280-290. [PMID: 17195232 DOI: 10.1002/art.22306] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 7.1] [Reference Citation Analysis]
637 Java A, Atkinson J, Salmon J. Defective complement inhibitory function predisposes to renal disease. Annu Rev Med 2013;64:307-24. [PMID: 23121180 DOI: 10.1146/annurev-med-072211-110606] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
638 Manna R, Ricci V, Curigliano V, Pomponi M, Adamo F, Costa A, De Socio G, D'onofrio F, Gasbarrini G, Bria P. Psychiatric Manifestations as a Primary Symptom in Antiphospholipid Syndrome. Int J Immunopathol Pharmacol 2006;19:915-7. [DOI: 10.1177/039463200601900421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
639 Khalife D, Ghazeeri G, Kutteh W. Review of current guidelines for recurrent pregnancy loss: new strategies for optimal evaluation of women who may be superfertile. Seminars in Perinatology 2019;43:105-15. [DOI: 10.1053/j.semperi.2018.12.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
640 Liu XL, Xiao J, Zhu F. Anti-β2 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome. Acta Obstetricia et Gynecologica Scandinavica 2013;92:234-7. [DOI: 10.1111/aogs.12038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
641 Mattia E, Tonello M, Del Ross T, Zerbinati P, Campello E, Simioni P, Ruffatti A. Clinical and laboratory characteristics of isolated lupus anticoagulants. Thromb Res 2018;165:51-3. [PMID: 29567587 DOI: 10.1016/j.thromres.2018.03.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
642 Lund M, Nielsen HS, Hviid TV, Steffensen R, Nyboe Andersen A, Christiansen OB. Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications. Hum Reprod 2010;25:2978-84. [PMID: 20937743 DOI: 10.1093/humrep/deq280] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
643 Cellini M, Santaguida MG, Stramazzo I, Capriello S, Brusca N, Antonelli A, Fallahi P, Gargano L, Centanni M, Virili C. Recurrent Pregnancy Loss in Women with Hashimoto's Thyroiditis with Concurrent Non-Endocrine Autoimmune Disorders. Thyroid 2020;30:457-62. [PMID: 31910128 DOI: 10.1089/thy.2019.0456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
644 Toth B, Würfel W, Bohlmann M, Zschocke J, Rudnik-Schöneborn S, Nawroth F, Schleußner E, Rogenhofer N, Wischmann T, von Wolff M, Hancke K, von Otte S, Kuon R, Feil K, Tempfer C. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050). Geburtshilfe Frauenheilkd 2018;78:364-81. [PMID: 29720743 DOI: 10.1055/a-0586-4568] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
645 Diz-Küçükkaya R. Lupus anticoagulant, thrombosis, and death. Blood 2015;125:3371-2. [PMID: 26022052 DOI: 10.1182/blood-2015-04-638320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
646 Su X, Wang A, Zhu H, Su H, Duan Y, Wu S, Zhang M, Huang Y, Zhou X, Cao Y. Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report : Anticardiolipin antibody and myocardial infarction. BMC Cardiovasc Disord 2019;19:156. [PMID: 31248367 DOI: 10.1186/s12872-019-1135-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
647 Artim-Esen B, Pericleous C, Mackie I, Ripoll VM, Latchman D, Isenberg D, Rahman A, Ioannou Y, Giles I. Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays. Arthritis Res Ther 2015;17:47. [PMID: 25890027 DOI: 10.1186/s13075-015-0568-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
648 Cetin Gedik K, Siddique S, Aguiar CL. Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome - report of three cases and review of the literature. Lupus 2018;27:1190-7. [PMID: 29320972 DOI: 10.1177/0961203317751853] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
649 de Melo Marques SH, Ferreira HAN, de Morais Nunes ATP, Silva RNP, Norton SMMS. Two Faces of the Same Coin: A Case Report of Antiphospholipid Syndrome Nephropathy. Eur J Case Rep Intern Med 2017;4:000542. [PMID: 30755930 DOI: 10.12890/2017_000542] [Reference Citation Analysis]
650 Fialová L, Petráčková M, Kuchař O. Comparison of different enzyme-linked immunosorbent assay methods for avidity determination of antiphospholipid antibodies. J Clin Lab Anal 2017;31. [PMID: 28124796 DOI: 10.1002/jcla.22121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
651 Karahan S, Erol K, Yuksel RC, Artan C, Celik I. Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit. Mod Rheumatol 2021;:1-10. [PMID: 33620009 DOI: 10.1080/14397595.2021.1892257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
652 Yoshinaga K, Otsuka Y, Furukawa T, Amitani S, Kimura N, Sanui M. Correlation between activated clotting time monitoring and heparin concentration measurement in a patient with antiphospholipid syndrome during cardiac valve surgery: a case report. JA Clin Rep 2021;7:24. [PMID: 33715057 DOI: 10.1186/s40981-021-00427-x] [Reference Citation Analysis]
653 Benjamin L, Khoo S. HIV infection and stroke. Handb Clin Neurol 2018;152:187-200. [PMID: 29604976 DOI: 10.1016/B978-0-444-63849-6.00015-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
654 Zhu R, Cheng C, Yang Y, Denas G, Pengo V. Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.04.021] [Reference Citation Analysis]
655 Scherer EM, Zwick MB, Teyton L, Burton DR. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS 2007;21:2131-9. [PMID: 18090039 DOI: 10.1097/QAD.0b013e3282a4a632] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
656 Polanski JF, Tanaka EA, Barros H, Chuchene AG, Miguel PTG, Skare TL. Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients. Laryngoscope 2021;131:E957-60. [PMID: 32603516 DOI: 10.1002/lary.28873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
657 Ceribelli A, Tincani A, Cavazzana I, Franceschini F, Cattaneo R, Pauley BA, Chan JY, Chan EK, Satoh M. Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). Autoimmunity 2011;44:90-7. [PMID: 20695766 DOI: 10.3109/08916934.2010.499886] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
658 Trese MG, Thanos A, Yonekawa Y, Randhawa S. Optical Coherence Tomography Angiography of Paracentral Acute Middle Maculopathy Associated With Primary Antiphospholipid Syndrome. Ophthalmic Surg Lasers Imaging Retina 2017;48:175-8. [DOI: 10.3928/23258160-20170130-13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
659 Zhang W, Wang F, Wang H, Hua B, Feng X, Sun L. Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases. Clin Rheumatol 2018;37:3337-44. [DOI: 10.1007/s10067-018-4312-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
660 Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa. Rheumatology 2008;48:508-12. [DOI: 10.1093/rheumatology/kep036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
661 Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 2017;76:476-85. [PMID: 27457513 DOI: 10.1136/annrheumdis-2016-209770] [Cited by in Crossref: 310] [Cited by in F6Publishing: 239] [Article Influence: 51.7] [Reference Citation Analysis]
662 Cohen H, Isenberg DA. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome. Blood 2021;137:299-309. [PMID: 32898856 DOI: 10.1182/blood.2020004942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
663 Lambrianides A, Carroll CJ, Pierangeli SS, Pericleous C, Branch W, Rice J, Latchman DS, Townsend P, Isenberg DA, Rahman A, Giles IP. Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways. J Immunol 2010;184:6622-8. [PMID: 20483743 DOI: 10.4049/jimmunol.0902765] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
664 Soh MC, Nelson-piercy C. Antiphospholipid syndrome in pregnancy. Expert Review of Obstetrics & Gynecology 2014;5:741-61. [DOI: 10.1586/eog.10.57] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
665 Mehta J. Laboratory testing in pediatric rheumatology. Pediatr Clin North Am 2012;59:263-84. [PMID: 22560570 DOI: 10.1016/j.pcl.2012.03.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
666 Carecchio M, Cantello R, Comi C. Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage. J Immunol Res 2014;2014:239398. [PMID: 24741580 DOI: 10.1155/2014/239398] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
667 Yang J, Liang M. Risk factors for pregnancy morbidity in women with antiphospholipid syndrome. J Reprod Immunol 2021;145:103315. [PMID: 33845396 DOI: 10.1016/j.jri.2021.103315] [Reference Citation Analysis]
668 Perdan-Pirkmajer K, Žigon P, Boc A, Podovšovnik E, Čučnik S, Mavri A, Rotar Ž, Ambrožič A. The Predictive Value of the aCL and Anti-β2GPI at the Time of Acute Deep Vein Thrombosis-A Two-Year Prospective Study. Biomedicines 2021;9:901. [PMID: 34440105 DOI: 10.3390/biomedicines9080901] [Reference Citation Analysis]
669 Urbanski G, Yelnik CM, Maillard H, Launay D, Dubucquoi S, Hachulla E, Hatron PY, Lambert M. Antiphospholipid Syndrome With Isolated Isotype M Anticardiolipin and/or Anti-B2GPI Antibody Is Associated With Stroke. Stroke 2018;49:2770-2. [PMID: 30355196 DOI: 10.1161/STROKEAHA.118.023021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
670 Arase N, Tanimura K, Jin H, Yamaoka T, Kishibe M, Nishioka M, Kiyohara E, Tani M, Matsuoka S, Ohmura K, Takasugi K, Yamamoto T, Murota H, Arase H, Katayama I. Novel autoantibody against the β2‐glycoprotein I/human leucocyte antigen– DR complex in patients with refractory cutaneous ulcers. Br J Dermatol 2017;178:272-5. [DOI: 10.1111/bjd.15571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
671 Koh JH, Park EK, Lee HN, Kim Y, Kim GT, Suh YS, Kim HO, Lee SG. Clinical characteristics and survival of 413 patients with systemic lupus erythematosus in southeastern areas of South Korea: A multicenter retrospective cohort study. Int J Rheum Dis 2020;23:92-100. [PMID: 31802639 DOI: 10.1111/1756-185X.13761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
672 Schlichtiger A, Luppa PB, Neumeier D, Thaler M. Biosensor approaches for the detection of autoantibodies in human serum. Bioanal Rev 2012;4:75-86. [DOI: 10.1007/s12566-012-0028-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
673 Biceroglu S, Ildizli Demirbas M, Karaca M, Yalcin M, Yilmaz H. Acute thrombotic occlusion of right coronary and left circumflex coronary arteries in a patient with antiphospholipid syndrome: successful stent implantation. Case Rep Med. 2010;2010:198594. [PMID: 21048929 DOI: 10.1155/2010/198594] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
674 Gonzalez-fiol A, Eisenberger A. Anesthesia implications of coagulation and anticoagulation during pregnancy. Seminars in Perinatology 2014;38:370-7. [DOI: 10.1053/j.semperi.2014.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
675 Ohmura K, Oku K, Kitaori T, Amengual O, Hisada R, Kanda M, Shimizu Y, Fujieda Y, Kato M, Bohgaki T, Horita T, Yasuda S, Sugiura-Ogasawara M, Atsumi T. Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss. Clin Immunol 2019;203:37-44. [PMID: 30974291 DOI: 10.1016/j.clim.2019.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
676 Benito-Garcia F, Pires I, Lima J. Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women. Medicina (Kaunas) 2021;57:390. [PMID: 33920569 DOI: 10.3390/medicina57040390] [Reference Citation Analysis]
677 Espinosa G, Cervera R. Thromboprophylaxis and obstetric management of the antiphospholipid syndrome. Expert Opinion on Pharmacotherapy 2009;10:601-14. [DOI: 10.1517/14656560902772302] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
678 Noureldine MHA, Nour-Eldine W, Khamashta MA, Uthman I. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome. Semin Arthritis Rheum 2019;48:860-6. [PMID: 30217394 DOI: 10.1016/j.semarthrit.2018.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
679 Lonati PA, Scavone M, Gerosa M, Borghi MO, Pregnolato F, Curreli D, Podda G, Femia EA, Barcellini W, Cattaneo M, Tedesco F, Meroni PL. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome. Front Immunol 2019;10:773. [PMID: 31031764 DOI: 10.3389/fimmu.2019.00773] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
680 Lu H, Hu R. The role of immunity in the pathogenesis and development of pre‐eclampsia. Scand J Immunol 2019;90. [DOI: 10.1111/sji.12756] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
681 Gardiner C, Vatish M. Impact of haemostatic mechanisms on pathophysiology of preeclampsia. Thromb Res 2017;151 Suppl 1:S48-52. [PMID: 28262234 DOI: 10.1016/S0049-3848(17)30067-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
682 Leaf RK, Connors JM. The Role of Anticoagulants in the Prevention of Pregnancy Complications. Clin Appl Thromb Hemost 2017;23:116-23. [DOI: 10.1177/1076029615615972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
683 Mineo C, Lanier L, Jung E, Sengupta S, Ulrich V, Sacharidou A, Tarango C, Osunbunmi O, Shen YM, Salmon JE, Brekken RA, Huang X, Thorpe PE, Shaul PW. Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis. PLoS One 2016;11:e0158757. [PMID: 27463336 DOI: 10.1371/journal.pone.0158757] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
684 Chighizola CB, de Jesus GR. Antiphospholipid antibodies and infertility. Lupus 2014;23:1232-8. [PMID: 25228713 DOI: 10.1177/0961203314529171] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
685 Ramirez GA, Rocca MA, Preziosa P, Bozzolo EP, Pagani E, Canti V, Moiola L, Rovere-Querini P, Manfredi AA, Filippi M. Quantitative MRI adds to neuropsychiatric lupus diagnostics. Rheumatology (Oxford) 2021;60:3278-88. [PMID: 33367829 DOI: 10.1093/rheumatology/keaa779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
686 Mena-Vázquez N, Fernández-Nebro A, Pego-Reigosa JM, Galindo M, Melissa-Anzola A, Uriarte-Isacelay E, Olivé-Marqués A, Aurrecoechea E, Freire M, Tomero E, García-Villanueva MJ, Stoye C, Salas-Heredia E, Bernal-Vidal JA, Salgado E, Blanco R, Javier Novoa F, Ibáñez-Barcelo M, Torrente-Segarra V, Narvaez J, Calvet J, Moriano Morales C, Ramon Vazquez-Rodriguez T, Garcia de la Peña P, Bohórquez C, Andreu-Sánchez JL, Cobo-Ibañez T, Bonilla G, Lozano-Rivas N, Montilla C, Toyos FJ, De la Fuente JLM, Expósito L, Ruiz-Lucea ME, Vals E, Manero-Ruiz J, Bernal-Vidal JA, Rua-Figueroa I. Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry. Rheumatology (Oxford) 2020;59:2043-51. [PMID: 31808534 DOI: 10.1093/rheumatology/kez562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
687 Erkan D, Kozora E, Lockshin MD. Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. Pathophysiology 2011;18:93-102. [PMID: 20472406 DOI: 10.1016/j.pathophys.2010.04.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
688 Tokutake T, Ieko M, Naito S, Yoshida M, Baba H, Kobayashi H, Ishida F. Magnesium‐dependent activated partial thromboplastin time assay—Simple method for lupus anticoagulant detection. Int J Lab Hematol 2019;42:46-51. [DOI: 10.1111/ijlh.13134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
689 Fukui S, Hirota S, Iwamoto N, Karata H, Kawakami A. Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review. Medicine (Baltimore) 2015;94:e2345. [PMID: 26705229 DOI: 10.1097/MD.0000000000002345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
690 Eilertsen GØ, Becker-merok A, Nossent JC. The Influence of the 1997 Updated Classification Criteria for Systemic Lupus Erythematosus: Epidemiology, Disease Presentation, and Patient Management. J Rheumatol 2009;36:552-9. [DOI: 10.3899/jrheum.080574] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
691 Tomimatsu T, Hazama Y, Takeuchi M, Kimura T, Shimoya K. Unresponsiveness to oxytocin due to an extremely thin uterine wall in a pregnant woman with systemic lupus erythematosus and Sjögren's syndrome. J Obstet Gynaecol 2018;38:276-8. [PMID: 28830255 DOI: 10.1080/01443615.2017.1340439] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
692 Nayfe R, Uthman I, Aoun J, Saad Aldin E, Merashli M, Khamashta MA. Seronegative antiphospholipid syndrome. Rheumatology (Oxford) 2013;52:1358-67. [PMID: 23502076 DOI: 10.1093/rheumatology/ket126] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
693 Tavil B, Ozyurek E, Gumruk F, Cetin M, Gurgey A. Antiphospholipid antibodies in Turkish children with thrombosis. Blood Coagul Fibrinolysis. 2007;18:347-352. [PMID: 17473576 DOI: 10.1097/mbc.0b013e32809cc95a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
694 Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Practice & Research Clinical Rheumatology 2007;21:1011-23. [DOI: 10.1016/j.berh.2007.09.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
695 Lim W. Antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2013;2013:675-680. [PMID: 24319251 DOI: 10.1182/asheducation-2013.1.675] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
696 Favaloro EJ, Wong RC. Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med 2011;49:447-61. [PMID: 21275808 DOI: 10.1515/CCLM.2011.064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
697 Martirosyan A, Aminov R, Manukyan G. Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation. Front Immunol 2019;10:1609. [PMID: 31354742 DOI: 10.3389/fimmu.2019.01609] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
698 Hudzik B, Szkodzinski J, Polonski L. Testing for antiphospholipid antibodies at autopsy. Forensic Sci Med Pathol 2014;10:288-9. [PMID: 24435954 DOI: 10.1007/s12024-014-9528-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
699 Wang TF, Lim W. What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies? Hematology Am Soc Hematol Educ Program 2016;2016:714-6. [PMID: 27913551 DOI: 10.1182/asheducation-2016.1.714] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
700 García-martín P, García-garcía C, Fraga J, García-díez A. Prevalencia de anticuerpos antifosfolípido en pacientes con lupus eritematoso cutáneo subagudo y crónico. Actas Dermo-Sifiliográficas 2013;104:232-8. [DOI: 10.1016/j.ad.2012.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2]